GLP-2T Peptide

$34.00 – $157.00 Select options

GLP-2T Peptide

Price range: $34.00 through $157.00

Research-grade GLP-2T Peptide for laboratory investigation. For Research Use Only. Not for human use.

Size: No selection

More options

Clear

COA GLP-2T COA-GLP-2T

For Research Use Only. Not for human use.

Overview

GLP-2T Peptide is supplied as a research-grade catalog material for controlled laboratory investigation.

Laboratories choose this item when protocols need clear identification, consistent labeling, and documentation suitable for reproducible experimental workflows.

Catalog packaging and research-use labeling help purchasing and bench teams keep procurement records aligned with the physical vial.

Research Context for GLP-2T Peptide

Work involving GLP-2T Peptide typically focuses on in vitro systems, assay development, and mechanistic model studies.

Teams confirm lot details before setup so conditions stay traceable across repeats and collaborative sites.

Published literature can inform starting ranges for related experimental designs. Each laboratory should still validate performance with its own instruments, plates, and detection chemistry.

Pilot runs are useful before committing larger plate sets, especially when detection chemistry or incubation windows are being optimized.

Documented Attributes

Key catalog attributes for this material include:

Research-grade material intended for laboratory investigation only
Catalog labeling aligned with research procurement channels
Suitable for method development and comparative assay workflows
Documentation packages available where provided for the listed lot

Laboratory Handling Notes

Receiving and Identity Checks

Before opening a vial of GLP-2T Peptide, confirm the physical label against the purchase order and packing list.

Retain outer packaging until identity checks are complete, and report damaged seals to purchasing before experimental work continues.

Reconstitution and Aliquoting

Handle this material according to institutional SOPs for weighing, reconstitution, aliquoting, and storage.

Record lot identifiers in laboratory notebooks before reconstitution. Verify solvent compatibility and storage temperature against your validated process.

Prepare assay buffers and consumables before opening the vial to reduce hold time. Keep unused aliquots labeled with date, solvent, and concentration for later repeats.

Chain of Custody

Keep chain-of-custody notes with inventory checks when material moves between freezers or benches.

Use dedicated spatulas and clean balances to avoid cross-contamination between catalog items. Schedule thaw cycles intentionally rather than repeated freeze-thaw of the same aliquot.

Secondary containment trays reduce spill risk during multi-step reconstitution. Cold-chain interruptions should be noted even when the vial remains sealed.

Why Laboratories Source GLP-2T Peptide

Procurement and research teams often select this catalog item because it supports:

Clear research-use labeling for compliance-aligned purchasing
Consistent product identification across multi-lot studies
Fit for reference, screening, and mechanistic laboratory models
Straightforward catalog support for planning and documentation

Study Planning and Quality Documentation

Before starting experimental work with GLP-2T Peptide, review any COA or quality files provided with the shipment.

Align your protocol with institutional research requirements and keep use within the labeled research context.

File catalog documentation with the study records at receipt. These steps help keep experiments comparable over time when using GLP-2T Peptide in sequential study phases.

Method Development Tips

Method development often begins with small pilot plates before larger screening panels.

Document buffer lots, incubation times, and detection settings alongside the material lot number.

If results diverge from historical baselines, re-check reconstitution volume and storage history first. Shared equipment logs help explain variance when multiple operators run the same protocol.

Inventory and Training

Update digital inventory immediately after opening a new lot of GLP-2T Peptide.

Training new staff on labeling conventions reduces mix-ups across similar catalog SKUs. When transferring methods between sites, share both the written SOP and the lot metadata package.

Dispose of residual solutions according to institutional chemical hygiene rules. Do not repurpose research materials for any non-laboratory application.

Periodic inventory reconciliation keeps expired or depleted lots from entering active workflows. For related catalog options, browse adjacent research categories on this site after confirming your assay needs.

For Research Use Only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease.

Peptide Research

For Research Use Only. Not for human use.

PubMed (NIH/NLM) records related to this compound for laboratory literature review. Inclusion does not imply suitability for any use beyond controlled research. Each note below is a research-framed summary using compliance-safe wording.

Showing 996 PubMed records. Displaying 10 per page.

Malhotra A et al. (2024). Tirzepatide for the investigation of Obstructive Sleep Apnea and metabolic research models [PMID: 38912654]
Laboratory literature summary: Tirzepatide for the investigation of Obstructive Sleep Apnea and metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jastreboff AM et al. (2022). Tirzepatide Once Weekly for the investigation of metabolic research models [PMID: 35658024]
Laboratory literature summary: Tirzepatide Once Weekly for the investigation of metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jastreboff AM et al. (2025). Laboratory research record on GLP-2T [PMID: 39536238]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Aronne LJ et al. (2025). Tirzepatide as Compared with Semaglutide for the investigation of metabolic research… [PMID: 40353578]
Laboratory literature summary: Tirzepatide as Compared with Semaglutide for the investigation of metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Frías JP et al. (2021). Laboratory research record on GLP-2T [PMID: 34170647]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Packer M et al. (2025). Tirzepatide for Heart Failure with Preserved Ejection Fraction and metabolic research… [PMID: 39555826]
Laboratory literature summary: Tirzepatide for Heart Failure with Preserved Ejection Fraction and metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nicholls SJ et al. (2025). Laboratory research record on GLP-2T [PMID: 41406444]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Zhao L et al. (2024). Laboratory research record on GLP-2T [PMID: 38819983]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Loomba R et al. (2024). Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis [PMID: 38856224]
Laboratory literature summary: Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rodriguez PJ et al. (2024). Laboratory research record on GLP-2T [PMID: 38976257]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Forzano I et al. (2022). Tirzepatide: A Systematic Update [PMID: 36498958]
Laboratory literature summary: Tirzepatide: A Systematic Update. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hamza M et al. (2025). Laboratory research record on GLP-2T [PMID: 39632534]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Willard FS et al. (2020). Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist [PMID: 32730231]
Laboratory literature summary: Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
France NL et al. (2024). Laboratory research record on GLP-2T [PMID: 38388874]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Gettman L (2023). Laboratory research record on GLP-2T [PMID: 36751934]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Sattar N et al. (2022). Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis [PMID: 35210595]
Laboratory literature summary: Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ravussin E et al. (2025). Tirzepatide did not impact metabolic adaptation in people with metabolic research… [PMID: 40203836]
Laboratory literature summary: Tirzepatide did not impact metabolic adaptation in people with metabolic research models, but increased fat oxidation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mishra R et al. (2023). Adverse Events Related to Tirzepatide [PMID: 36789109]
Laboratory literature summary: Adverse Events Related to Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Regmi A et al. (2024). Tirzepatide modulates the regulation of adipocyte nutrient metabolism through… [PMID: 38878772]
Laboratory literature summary: Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sinha R et al. (2023). Laboratory research record on GLP-2T [PMID: 36750526]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Sumithran P et al. (2025). Cardiovascular effects of tirzepatide [PMID: 39751188]
Laboratory literature summary: Cardiovascular effects of tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (1994). Laboratory research record on GLP-2T [PMID: 39038307]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Baker DE et al. (2023). Laboratory research record on GLP-2T [PMID: 37216078]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Samms RJ et al. (2021). Laboratory research record on GLP-2T [PMID: 34003802]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Jalleh RJ et al. (2024). Laboratory Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and… [PMID: 39418085]
Laboratory literature summary: laboratory Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Quarenghi M et al. (2025). Laboratory research record on GLP-2T [PMID: 40507553]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Farzam K et al. (2026). Laboratory research record on GLP-2T [PMID: 36251836]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Bagherzadeh-Rahmani B et al. (2024). Tirzepatide and exercise training in metabolic research models [PMID: 38640145]
Laboratory literature summary: Tirzepatide and exercise training in metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yang D et al. (2025). Tirzepatide alleviates doxorubicin-induced cardiotoxicity via inhibiting HRD1-mediated… [PMID: 40036855]
Laboratory literature summary: Tirzepatide alleviates doxorubicin-induced cardiotoxicity via inhibiting HRD1-mediated Nrf2 ubiquitination. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Schneck K et al. (2024). Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide [PMID: 38356317]
Laboratory literature summary: Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Franco JV et al. (2025). Tirzepatide for adults living with metabolic research models [PMID: 41161687]
Laboratory literature summary: Tirzepatide for adults living with metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2012). Laboratory research record on GLP-2T [PMID: 35780672]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Quddos F et al. (2023). Semaglutide and Tirzepatide reduce alcohol consumption in individuals with metabolic… [PMID: 38017205]
Laboratory literature summary: Semaglutide and Tirzepatide reduce alcohol consumption in individuals with metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Greenway FL (2025). Semaglutide and Tirzepatide to Treat metabolic research models [PMID: 40601944]
Laboratory literature summary: Semaglutide and Tirzepatide to Treat metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2006). Laboratory research record on GLP-2T [PMID: 35759552]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Sattar N et al. (2025). Tirzepatide and cardiometabolic parameters in metabolic research models: Summary of… [PMID: 40555920]
Laboratory literature summary: Tirzepatide and cardiometabolic parameters in metabolic research models: Summary of current evidence. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Beccuti G et al. (2024). Estimating Cardiovascular Benefits of Tirzepatide in Sleep Apnea and metabolic… [PMID: 39378016]
Laboratory literature summary: Estimating Cardiovascular Benefits of Tirzepatide in Sleep Apnea and metabolic research models: Insight from the SURMOUNT-OSA Trials. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lin F et al. (2023). Body-composition research efficiency and laboratory profile of tirzepatide: A… [PMID: 37141329]
Laboratory literature summary: body-composition research efficiency and laboratory profile of tirzepatide: A Systematic review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Taktaz F et al. (2024). Laboratory research record on GLP-2T [PMID: 38555463]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Anala AD et al. (2023). The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome [PMID: 37510690]
Laboratory literature summary: The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Venniyoor A (2022). Tirzepatide Once Weekly for the investigation of metabolic research models [PMID: 36239654]
Laboratory literature summary: Tirzepatide Once Weekly for the investigation of metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hwang JH et al. (2025). Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults [PMID: 40085108]
Laboratory literature summary: Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Corrao S et al. (2024). Tirzepatide against metabolic research models and insulin-resistance:… [PMID: 38978621]
Laboratory literature summary: Tirzepatide against metabolic research models and insulin-resistance: pathophysiological aspects and laboratory evidence. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Alshehri GH et al. (2025). Tirzepatide: a novel investigational approach for neurodegeneration research models's… [PMID: 40498212]
Laboratory literature summary: Tirzepatide: a novel investigational approach for neurodegeneration research models's disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hidalgo Ramos RA et al. (2025). Effects of Tirzepatide on Skeletal Muscle Mass in Adults: A Systematic Review [PMID: 40895971]
Laboratory literature summary: Effects of Tirzepatide on Skeletal Muscle Mass in Adults: A Systematic Review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fontanella RA et al. (2024). Tirzepatide prevents neurodegeneration through multiple molecular pathways [PMID: 38287296]
Laboratory literature summary: Tirzepatide prevents neurodegeneration through multiple molecular pathways. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Brož J et al. (2026). Laboratory research record on GLP-2T [PMID: 42334912]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Syed YY (2022). Tirzepatide: First Approval [PMID: 35830001]
Laboratory literature summary: Tirzepatide: First Approval. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Katz BJ et al. (2025). Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and… [PMID: 39883468]
Laboratory literature summary: Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sun B et al. (2022). Structural determinants of dual incretin receptor agonism by tirzepatide [PMID: 35333651]
Laboratory literature summary: Structural determinants of dual incretin receptor agonism by tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Martin JA et al. (2024). Absorption, distribution, metabolism, and excretion of tirzepatide in research… [PMID: 39243911]
Laboratory literature summary: Absorption, distribution, metabolism, and excretion of tirzepatide in research subjects, rats, and monkeys. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Xia Y et al. (2024). Tirzepatide's role in targeting adipose tissue macrophages to reduce metabolic… [PMID: 39471690]
Laboratory literature summary: Tirzepatide's role in targeting adipose tissue macrophages to reduce metabolic research models-related inflammation and improve insulin…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lin HT et al. (2025). Laboratory research record on GLP-2T [PMID: 40663350]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Ferrannini E (2022). Tirzepatide as an Insulin Sensitizer [PMID: 34788445]
Laboratory literature summary: Tirzepatide as an Insulin Sensitizer. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Heerspink HJL et al. (2025). Laboratory research record on GLP-2T [PMID: 40512543]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Author et al. (2024). Tirzepatide for the investigation of Obstructive Sleep Apnea and metabolic research models [PMID: 39413392]
Laboratory literature summary: Tirzepatide for the investigation of Obstructive Sleep Apnea and metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Galindo RJ et al. (2026). Insights into the Mechanism of Action of Tirzepatide: A Narrative Review [PMID: 41196501]
Laboratory literature summary: Insights into the Mechanism of Action of Tirzepatide: A Narrative Review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wu JY et al. (2025). Laboratory Impact of Tirzepatide on research subjects With OSA and metabolic research… [PMID: 40254150]
Laboratory literature summary: laboratory Impact of Tirzepatide on research subjects With OSA and metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Horn DB et al. (2025). Time to weight plateau with tirzepatide investigation in the SURMOUNT-1 and SURMOUNT-4… [PMID: 39800653]
Laboratory literature summary: Time to weight plateau with tirzepatide investigation in the SURMOUNT-1 and SURMOUNT-4 laboratory trials. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Geisler CE et al. (2023). Tirzepatide suppresses palatable food intake by selectively reducing preference for… [PMID: 36054312]
Laboratory literature summary: Tirzepatide suppresses palatable food intake by selectively reducing preference for fat in rodents. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mercer J et al. (2023). Tirzepatide-associated starvation ketoacidosis [PMID: 37938168]
Laboratory literature summary: Tirzepatide-associated starvation ketoacidosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
El-Amawy HS (2026). Tirzepatide in dermatology: cutaneous adverse events, emerging investigational roles,… [PMID: 41483501]
Laboratory literature summary: Tirzepatide in dermatology: cutaneous adverse events, emerging investigational roles, and cosmetic implications – A comprehensive review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Meral R et al. (2024). Tirzepatide for Lipodystrophy [PMID: 39802778]
Laboratory literature summary: Tirzepatide for Lipodystrophy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Olowo-Oribi BA et al. (2025). Laboratory research record on GLP-2T [PMID: 40583149]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Mullins GR et al. (2024). Tirzepatide Immunogenicity on Pharmacokinetics, observed endpoints, and laboratory… [PMID: 37700637]
Laboratory literature summary: Tirzepatide Immunogenicity on Pharmacokinetics, observed endpoints, and laboratory profile: Analysis of Data From Phase 3 Studies. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Malhotra A et al. (2025). Tirzepatide for sleep-disordered breathing in SURMOUNT-OSA: Time course and… [PMID: 41135142]
Laboratory literature summary: Tirzepatide for sleep-disordered breathing in SURMOUNT-OSA: Time course and association with body weight. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ceriello A et al. (2026). Causes and consequences of discontinuation of GLP1RAs or tirzepatide [PMID: 42168641]
Laboratory literature summary: Causes and consequences of discontinuation of GLP1RAs or tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wang L et al. (2025). Laboratory research record on GLP-2T [PMID: 40788646]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Bayless D et al. (2024). Tirzepatide-Associated Colonic Ischemia [PMID: 39507503]
Laboratory literature summary: Tirzepatide-Associated Colonic Ischemia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Snell-Bergeon JK et al. (2025). Laboratory research record on GLP-2T [PMID: 39745353]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
El K et al. (2023). The incretin co-agonist tirzepatide requires GIPR for hormone secretion from research… [PMID: 37277609]
Laboratory literature summary: The incretin co-agonist tirzepatide requires GIPR for hormone secretion from research subjects islets. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Samms RJ et al. (2022). Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue [PMID: 35921984]
Laboratory literature summary: Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Anderson SL et al. (2023). Laboratory research record on GLP-2T [PMID: 37664792]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Crisafulli S et al. (2026). Laboratory research record on GLP-2T [PMID: 41183330]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Lin YM et al. (2025). Effectiveness of tirzepatide in research subjects with HFpEF using a target trial… [PMID: 40368924]
Laboratory literature summary: Effectiveness of tirzepatide in research subjects with HFpEF using a target trial emulation retrospective cohort study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Glenny EM et al. (2024). Laboratory research record on GLP-2T [PMID: 38328151]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Betensky DJ et al. (2025). The Cost-Effectiveness of Semaglutide and Tirzepatide for research subjects With Knee… [PMID: 40953447]
Laboratory literature summary: The Cost-Effectiveness of Semaglutide and Tirzepatide for research subjects With Knee Osteoarthritis and metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chipkin SR (2022). Laboratory research record on GLP-2T [PMID: 35133426]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Dekker TJA (2022). Tirzepatide Once Weekly for the investigation of metabolic research models [PMID: 36239652]
Laboratory literature summary: Tirzepatide Once Weekly for the investigation of metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hagerich K et al. (2022). Tirzepatide Once Weekly for the investigation of metabolic research models [PMID: 36239653]
Laboratory literature summary: Tirzepatide Once Weekly for the investigation of metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Abdullah I et al. (2024). Tirzepatide-Related Acute Liver Injury [PMID: 39247248]
Laboratory literature summary: Tirzepatide-Related Acute Liver Injury. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kim C et al. (2025). Uptake of and Disparities in Semaglutide and Tirzepatide Prescribing for metabolic… [PMID: 40299371]
Laboratory literature summary: Uptake of and Disparities in Semaglutide and Tirzepatide Prescribing for metabolic research models in the US. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Muskiet MHA et al. (2025). Tirzepatide vs. Semaglutide for metabolic research models investigation [PMID: 41124642]
Laboratory literature summary: Tirzepatide vs. Semaglutide for metabolic research models investigation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2026). Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis [PMID: 41880634]
Laboratory literature summary: Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2023). Laboratory research record on GLP-2T [PMID: 38152319]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Alshehri GH et al. (2025). A novel investigational prospect: a dual-acting tirzepatide for neurodegeneration… [PMID: 40706971]
Laboratory literature summary: A novel investigational prospect: a dual-acting tirzepatide for neurodegeneration research models's disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Beninger P (2023). New Drug Capsule: Tirzepatide [PMID: 36870873]
Laboratory literature summary: New Drug Capsule: Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cowart K et al. (2025). Laboratory research record on GLP-2T [PMID: 40614622]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Jastreboff AM et al. (2022). Tirzepatide Once Weekly for the investigation of metabolic research models. Reply [PMID: 36239655]
Laboratory literature summary: Tirzepatide Once Weekly for the investigation of metabolic research models. Reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ten S et al. (2025). Tirzepatide for Congenital Generalized Lipodystrophy [PMID: 39886995]
Laboratory literature summary: Tirzepatide for Congenital Generalized Lipodystrophy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gasoyan H et al. (2025). Reasons for Discontinuation of metabolic research models Pharmacotherapy With… [PMID: 41039650]
Laboratory literature summary: Reasons for Discontinuation of metabolic research models Pharmacotherapy With Semaglutide or Tirzepatide in laboratory Practice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Iqbal PMR et al. (2024). Laboratory research record on GLP-2T [PMID: 38584893]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Bhatnagar P et al. (2025). Laboratory research record on GLP-2T [PMID: 40858971]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Regmi A et al. (2024). Tirzepatide modulates the regulation of adipocyte nutrient metabolism through… [PMID: 38945123]
Laboratory literature summary: Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mizumoto J (2023). Tirzepatide-Induced parenteral-route administration Site Reaction [PMID: 37842452]
Laboratory literature summary: Tirzepatide-Induced parenteral-route administration Site Reaction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mondoh A et al. (2025). Tirzepatide vs. semaglutide: laboratory decision-making in the GLP-1 landscape [PMID: 41351384]
Laboratory literature summary: Tirzepatide vs. semaglutide: laboratory decision-making in the GLP-1 landscape. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ghaleb J et al. (2025). Unveiling Tirzepatide's investigational Spectrum: A Dual GIP/GLP-1 Agonist Targeting… [PMID: 41069980]
Laboratory literature summary: Unveiling Tirzepatide's investigational Spectrum: A Dual GIP/GLP-1 Agonist Targeting Metabolic, Neurological, and Cardiovascular Health. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Liu Y et al. (2026). Skeletal effect of semaglutide and tirzepatide in research subjects with increased… [PMID: 41655226]
Laboratory literature summary: Skeletal effect of semaglutide and tirzepatide in research subjects with increased risk of fractures. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jia W et al. (2024). Tirzepatide-New Evidence for the investigation of metabolic research models From China [PMID: 38819984]
Laboratory literature summary: Tirzepatide-New Evidence for the investigation of metabolic research models From China. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sallam M et al. (2024). Shifting the Scales: Tirzepatide's Breakthrough in metabolic research models Management [PMID: 38887332]
Laboratory literature summary: Shifting the Scales: Tirzepatide's Breakthrough in metabolic research models Management. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shukla AK et al. (2025). Laboratory research record on GLP-2T [PMID: 40561544]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Aronne LJ (2025). Tirzepatide vs. Semaglutide for metabolic research models investigation. Reply [PMID: 41124644]
Laboratory literature summary: Tirzepatide vs. Semaglutide for metabolic research models investigation. Reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Birkenfeld AL et al. (2025). Laboratory research record on GLP-2T [PMID: 40561543]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Abdullayev N et al. (2025). Tirzepatide vs. Semaglutide for metabolic research models investigation [PMID: 41124643]
Laboratory literature summary: Tirzepatide vs. Semaglutide for metabolic research models investigation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ghoneim S (2023). Tirzepatide: A New Anti-metabolic research models Medication [PMID: 36155186]
Laboratory literature summary: Tirzepatide: A New Anti-metabolic research models Medication. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gasoyan H et al. (2026). Metabolic research models experimental regimens and Weight Changes in laboratory Practice After… [PMID: 41816857]
Laboratory literature summary: metabolic research models experimental regimens and Weight Changes in laboratory Practice After Discontinuation of Semaglutide or Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bosch C et al. (2023). Tirzepatide and prevention of chronic kidney disease [PMID: 37151412]
Laboratory literature summary: Tirzepatide and prevention of chronic kidney disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Huston J et al. (2026). Effect of Tirzepatide on Cardiovascular Outcomes [PMID: 41032189]
Laboratory literature summary: Effect of Tirzepatide on Cardiovascular Outcomes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Samuels JM et al. (2025). Real-world titration, persistence & body-composition research of semaglutide and… [PMID: 40762026]
Laboratory literature summary: Real-world titration, persistence & body-composition research of semaglutide and tirzepatide in an academic metabolic research models clinic. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Scheen A (2024). Laboratory research record on GLP-2T [PMID: 39697128]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Gasoyan H et al. (2025). Changes in weight and glycemic control following metabolic research models… [PMID: 40491239]
Laboratory literature summary: Changes in weight and glycemic control following metabolic research models investigation with semaglutide or tirzepatide by…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Karakus KE et al. (2024). Tirzepatide-Induced Rapid body-composition research-Related Thyrotoxicosis [PMID: 39102259]
Laboratory literature summary: Tirzepatide-Induced Rapid body-composition research-Related Thyrotoxicosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhang N et al. (2025). Reassessing retinopathy risk with tirzepatide research protocol [PMID: 41051411]
Laboratory literature summary: Reassessing retinopathy risk with tirzepatide research protocol. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jastreboff AM et al. (2025). Laboratory research record on GLP-2T [PMID: 40561545]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Krauss Z et al. (2023). Tirzepatide: laboratory review of the "twincretin" parenteral-route administration [PMID: 37070418]
Laboratory literature summary: Tirzepatide: laboratory review of the "twincretin" parenteral-route administration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lv F et al. (2024). Laboratory research record on GLP-2T [PMID: 39770498]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Andraos J et al. (2023). Beyond glycemia: Comparing tirzepatide to GLP-1 analogues [PMID: 37526853]
Laboratory literature summary: Beyond glycemia: Comparing tirzepatide to GLP-1 analogues. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Karrar HR et al. (2023). Tirzepatide-Induced Gastrointestinal Manifestations: A Systematic Review and Meta-Analysis [PMID: 37908927]
Laboratory literature summary: Tirzepatide-Induced Gastrointestinal Manifestations: A Systematic Review and Meta-Analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Aminorroaya A et al. (2025). Laboratory research record on GLP-2T [PMID: 40368575]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Niedbala CG et al. (2023). Tirzepatide: A promising investigation for metabolic research models? [PMID: 37884034]
Laboratory literature summary: Tirzepatide: A promising investigation for metabolic research models?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cheung KA et al. (2025). Tirzepatide for body-composition research [PMID: 41285630]
Laboratory literature summary: Tirzepatide for body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sokary S et al. (2025). The promise of tirzepatide: A narrative review of metabolic benefits [PMID: 40221292]
Laboratory literature summary: The promise of tirzepatide: A narrative review of metabolic benefits. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2023). Laboratory research record on GLP-2T [PMID: 38133594]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Edvardsson CE et al. (2026). Tirzepatide reduces alcohol drinking and relapse-like behaviours in rodents [PMID: 41506148]
Laboratory literature summary: Tirzepatide reduces alcohol drinking and relapse-like behaviours in rodents. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fushimi Y et al. (2025). Rhabdomyolysis triggered by initiation of tirzepatide [PMID: 40607146]
Laboratory literature summary: Rhabdomyolysis triggered by initiation of tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2022). Laboratory research record on GLP-2T [PMID: 35802842]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Targher G (2022). Tirzepatide adds hepatoprotection to its armoury [PMID: 35468320]
Laboratory literature summary: Tirzepatide adds hepatoprotection to its armoury. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tysoe O (2022). Tirzepatide highly effective for body-composition research [PMID: 35760842]
Laboratory literature summary: Tirzepatide highly effective for body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Novikoff A et al. (2025). Tirzepatide differentially affects body weight in mice and research subjects [PMID: 40490496]
Laboratory literature summary: Tirzepatide differentially affects body weight in mice and research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mando N et al. (2024). Acute Pancreatitis Caused by Tirzepatide [PMID: 39834977]
Laboratory literature summary: Acute Pancreatitis Caused by Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Janić M et al. (2026). Tirzepatide data: laboratory profile first is laboratory profile always! [PMID: 42201797]
Laboratory literature summary: Tirzepatide data: laboratory profile first is laboratory profile always!. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Slomski A (2022). Tirzepatide Trial Demonstrates Substantial body-composition research [PMID: 35881126]
Laboratory literature summary: Tirzepatide Trial Demonstrates Substantial body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bernardi JC et al. (2026). Who Wins the Battle Against metabolic research models? A Network Meta-Analysis… [PMID: 41664890]
Laboratory literature summary: Who Wins the Battle Against metabolic research models? A Network Meta-Analysis Comparing Tirzepatide and Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Varadinova M et al. (2025). Predicting Sustained Benefit From Tirzepatide in SURPASS-4: Who Benefits and Why? [PMID: 40971612]
Laboratory literature summary: Predicting Sustained Benefit From Tirzepatide in SURPASS-4: Who Benefits and Why?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tentolouris A et al. (2026). Laboratory research record on GLP-2T [PMID: 41565568]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Eldib M et al. (2026). Tirzepatide-associated interstitial kidney injury [PMID: 42093865]
Laboratory literature summary: Tirzepatide-associated interstitial kidney injury. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yu WS et al. (2025). Association of tirzepatide and the risk of suicide in a real-world cohort [PMID: 41334076]
Laboratory literature summary: Association of tirzepatide and the risk of suicide in a real-world cohort. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Angelopoulos N et al. (2026). Laboratory research record on GLP-2T [PMID: 41354867]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Copur S et al. (2023). Tirzepatide and potential use for metabolically healthy metabolic research models [PMID: 37183081]
Laboratory literature summary: Tirzepatide and potential use for metabolically healthy metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dutta P et al. (2023). Laboratory research record on GLP-2T [PMID: 37265914]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Nasoufidou A et al. (2025). Cardiovascular observed endpoints of tirzepatide: what real-world evidence promises [PMID: 41199614]
Laboratory literature summary: Cardiovascular observed endpoints of tirzepatide: what real-world evidence promises. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pagidipati NJ (2025). Holistic View of Tirzepatide's Role in metabolic research models-Related HFpEF [PMID: 40063724]
Laboratory literature summary: Holistic View of Tirzepatide's Role in metabolic research models-Related HFpEF. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rzepiński Ł et al. (2025). Laboratory research record on GLP-2T [PMID: 41465455]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Mi L et al. (2026). Tirzepatide retention in iWAT with mesoporous polydopamine encapsulation enhances… [PMID: 40945849]
Laboratory literature summary: Tirzepatide retention in iWAT with mesoporous polydopamine encapsulation enhances body-composition research through leptin receptor…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bertsch T (2022). An Introduction to Tirzepatide [PMID: 35983423]
Laboratory literature summary: An Introduction to Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Phelan LN et al. (2025). Not Just Skin Deep: A Hidden Complication of Tirzepatide research protocol [PMID: 40906268]
Laboratory literature summary: Not Just Skin Deep: A Hidden Complication of Tirzepatide research protocol. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Samuel SM et al. (2022). Laboratory research record on GLP-2T [PMID: 36358930]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Choi W et al. (2025). Brain activity associated with breakthrough food preoccupation in an individual on… [PMID: 41249493]
Laboratory literature summary: Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Koufakis T et al. (2023). Laboratory research record on GLP-2T [PMID: 37450311]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Hindson J (2022). Tirzepatide to treat metabolic research models: phase III results [PMID: 35773392]
Laboratory literature summary: Tirzepatide to treat metabolic research models: phase III results. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Venkatakrishnan AJ et al. (2026). Body-composition research dynamics with tirzepatide versus semaglutide [PMID: 42311474]
Laboratory literature summary: body-composition research dynamics with tirzepatide versus semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Stefan N (2025). Does tirzepatide investigation improve skeletal muscle composition? [PMID: 40318684]
Laboratory literature summary: Does tirzepatide investigation improve skeletal muscle composition?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chandani DK et al. (2025). Metabolic miracle or misguided shift? Tirzepatide in the era of obstructive sleep… [PMID: 41377342]
Laboratory literature summary: Metabolic miracle or misguided shift? Tirzepatide in the era of obstructive sleep apnea (OSA). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kim C et al. (2025). Semaglutide and Tirzepatide Prescribing for metabolic research models in research… [PMID: 41196576]
Laboratory literature summary: Semaglutide and Tirzepatide Prescribing for metabolic research models in research subjects With Preexisting Comorbid Cancers. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fisher CM et al. (2025). Tirzepatide-induced lichen planus pigmentosus [PMID: 41394532]
Laboratory literature summary: Tirzepatide-induced lichen planus pigmentosus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Scheen AJ (2022). Add-on value of tirzepatide versus semaglutide [PMID: 35468323]
Laboratory literature summary: Add-on value of tirzepatide versus semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shil KK et al. (2025). Observed endpoints and laboratory profile of Tirzepatide and Semaglutide for metabolic… [PMID: 41523559]
Laboratory literature summary: observed endpoints and laboratory profile of Tirzepatide and Semaglutide for metabolic research models Management: A Real-World Comparison. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nagendra L et al. (2024). Bariatric surgery and tirzepatide-Friends, not foes! [PMID: 38978177]
Laboratory literature summary: Bariatric surgery and tirzepatide-Friends, not foes!. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Maung ST et al. (2026). Real world tirzepatide investigation for fatty liver disease [PMID: 41776028]
Laboratory literature summary: Real world tirzepatide investigation for fatty liver disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhu Z et al. (2025). Tirzepatide and Kidney Protection in metabolic research models: Unanswered Questions [PMID: 40960876]
Laboratory literature summary: Tirzepatide and Kidney Protection in metabolic research models: Unanswered Questions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chan G et al. (2025). Appendicitis After Initiation of Tirzepatide [PMID: 39906694]
Laboratory literature summary: Appendicitis After Initiation of Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Várkonyi TT et al. (2023). Laboratory research record on GLP-2T [PMID: 37279858]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Al-Kuraishy HM et al. (2025). The mechanistic role of tirzepatide in atherosclerosis: A review [PMID: 40972917]
Laboratory literature summary: The mechanistic role of tirzepatide in atherosclerosis: A review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Meral R et al. (2025). Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option? [PMID: 40063619]
Laboratory literature summary: Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cesaro A et al. (2026). Tirzepatide and semaglutide: different twins? [PMID: 42099488]
Laboratory literature summary: Tirzepatide and semaglutide: different twins?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Afridi Z et al. (2025). Tirzepatide: a dual-action solution for obstructive sleep apnea and metabolic research… [PMID: 40110282]
Laboratory literature summary: Tirzepatide: a dual-action solution for obstructive sleep apnea and metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Windram M et al. (2026). Semaglutide, tirzepatide, and retatrutide attenuate the interoceptive effects of… [PMID: 40699363]
Laboratory literature summary: Semaglutide, tirzepatide, and retatrutide attenuate the interoceptive effects of alcohol in research models and research models rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Abdi A et al. (2025). Tirzepatide associated autoimmune encephalitis: A case report [PMID: 40609684]
Laboratory literature summary: Tirzepatide associated autoimmune encephalitis: A case report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kelsey MD et al. (2026). Laboratory research record on GLP-2T [PMID: 42006419]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Sumaruth Y et al. (2025). A Probable Case of Tirzepatide-Induced Acute Pancreatitis [PMID: 40612832]
Laboratory literature summary: A Probable Case of Tirzepatide-Induced Acute Pancreatitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Qian F et al. (2024). Observed endpoints of Tirzepatide for body-composition research in China: Implications… [PMID: 38819975]
Laboratory literature summary: observed endpoints of Tirzepatide for body-composition research in China: Implications for the Global metabolic research models Epidemic. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ma J et al. (2025). Laboratory research record on GLP-2T [PMID: 41458627]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Brijmohan S et al. (2025). Successful investigation of Hypothalamic metabolic research models with Tirzepatide [PMID: 40677794]
Laboratory literature summary: Successful investigation of Hypothalamic metabolic research models with Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sohal A et al. (2024). A Rare Case of Tirzepatide-Induced Hepatotoxicity [PMID: 39372916]
Laboratory literature summary: A Rare Case of Tirzepatide-Induced Hepatotoxicity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Marinho TS et al. (2026). Tirzepatide reverses hypothalamic inflammation, cellular stress, and neuropeptide… [PMID: 41407242]
Laboratory literature summary: Tirzepatide reverses hypothalamic inflammation, cellular stress, and neuropeptide imbalance in metabolic-menopausal dysfunction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Copur S et al. (2023). Tirzepatide decreases systolic and diastolic blood pressure [PMID: 37045710]
Laboratory literature summary: Tirzepatide decreases systolic and diastolic blood pressure. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Coppenrath V et al. (2024). Laboratory research record on GLP-2T [PMID: 39172681]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Dobbie LJ et al. (2025). Tirzepatide and the NHS: are we creating a two-tier metabolic research models… [PMID: 41167963]
Laboratory literature summary: Tirzepatide and the NHS: are we creating a two-tier metabolic research models investigation system?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tchang BG et al. (2026). Tirzepatide Heralds the Hope of Chronic Disease Eradication [PMID: 40754464]
Laboratory literature summary: Tirzepatide Heralds the Hope of Chronic Disease Eradication. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fadini GP (2025). Laboratory research record on GLP-2T [PMID: 41051409]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Patoulias D et al. (2026). Laboratory research record on GLP-2T [PMID: 41339161]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Kumar A (2023). Will Tirzepatide Become a Game-Changer Anti-metabolic research models Drug? [PMID: 37250871]
Laboratory literature summary: Will Tirzepatide Become a Game-Changer Anti-metabolic research models Drug?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nduma B et al. (2025). A potential association between tirzepatide and hypercalcemia in the setting of… [PMID: 40911613]
Laboratory literature summary: A potential association between tirzepatide and hypercalcemia in the setting of chronic hydrochlorothiazide use. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sidhu JK et al. (2025). A New Drug for metabolic research models: Tirzepatide [PMID: 38994609]
Laboratory literature summary: A New Drug for metabolic research models: Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Al-Horani RA et al. (2023). Laboratory research record on GLP-2T [PMID: 36200219]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wen J et al. (2025). Exploring the Effects of Tirzepatide on Obstructive Sleep Apnea: A Literature Review [PMID: 40190919]
Laboratory literature summary: Exploring the Effects of Tirzepatide on Obstructive Sleep Apnea: A Literature Review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sun M et al. (2026). Interpreting Post-Discontinuation Trajectories After Semaglutide or Tirzepatide [PMID: 41873004]
Laboratory literature summary: Interpreting Post-Discontinuation Trajectories After Semaglutide or Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kurinami N et al. (2025). Laboratory research record on GLP-2T [PMID: 41088952]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Bodanowitz JM et al. (2025). Case Report: Rhabdomyolysis following initiation of tirzepatide [PMID: 40910008]
Laboratory literature summary: Case Report: Rhabdomyolysis following initiation of tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Frey C (2026). Disproportionality Analysis of Tirzepatide-Associated Ketoacidosis [PMID: 42248357]
Laboratory literature summary: Disproportionality Analysis of Tirzepatide-Associated Ketoacidosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Corbalan JJ et al. (2025). The inhibitor VB-87531 synergizes with tirzepatide and semaglutide for greater… [PMID: 40694906]
Laboratory literature summary: The inhibitor VB-87531 synergizes with tirzepatide and semaglutide for greater body-composition research in DIO mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Robertson P et al. (2025). Shaping the UK's long term relationship with tirzepatide [PMID: 40021222]
Laboratory literature summary: Shaping the UK's long term relationship with tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Khurshid BN et al. (2025). Laboratory research record on GLP-2T [PMID: 41113899]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Yang J et al. (2024). Laboratory research record on GLP-2T [PMID: 39263564]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Author et al. (2025). Tirzepatide drives body-composition research in people with metabolic research models… [PMID: 40913173]
Laboratory literature summary: Tirzepatide drives body-composition research in people with metabolic research models due to MC4R deficiency. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Herman R et al. (2025). Laboratory research record on GLP-2T [PMID: 40847412]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Bardhan M et al. (2024). Tirzepatide, a dual incretin analog, is a boon in metabolic syndrome: an editorial [PMID: 38463093]
Laboratory literature summary: Tirzepatide, a dual incretin analog, is a boon in metabolic syndrome: an editorial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yang S et al. (2024). Tirzepatide shows neuroprotective effects via regulating brain glucose metabolism in… [PMID: 39002758]
Laboratory literature summary: Tirzepatide shows neuroprotective effects via regulating brain glucose metabolism in APP/PS1 mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ali MK (2025). Tirzepatide for Heart Failure and metabolic research models [PMID: 40267439]
Laboratory literature summary: Tirzepatide for Heart Failure and metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2025). Laboratory research record on GLP-2T [PMID: 39946698]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Krakauer JC et al. (2025). Tirzepatide for Heart Failure and metabolic research models [PMID: 40267437]
Laboratory literature summary: Tirzepatide for Heart Failure and metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Marine JE et al. (2025). Tirzepatide for Heart Failure and metabolic research models [PMID: 40267438]
Laboratory literature summary: Tirzepatide for Heart Failure and metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wagner J (2025). Tirzepatide for Heart Failure and metabolic research models [PMID: 40267436]
Laboratory literature summary: Tirzepatide for Heart Failure and metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ter Maaten JM et al. (2025). Tirzepatide, HFpEF, and the Kidney: A Triangular Relationship Requiring Measurement of… [PMID: 40183720]
Laboratory literature summary: Tirzepatide, HFpEF, and the Kidney: A Triangular Relationship Requiring Measurement of GFR, Not Guesses. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Parlati AL et al. (2026). Tirzepatide and the Cardiovascular Continuum: Metabolic, Cardiorenal and Heart Failure… [PMID: 42317617]
Laboratory literature summary: Tirzepatide and the Cardiovascular Continuum: Metabolic, Cardiorenal and Heart Failure Evidence. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Iftikhar P et al. (2025). Assessing the laboratory profile of Semaglutide and Tirzepatide in Black and Asian… [PMID: 40755607]
Laboratory literature summary: Assessing the laboratory profile of Semaglutide and Tirzepatide in Black and Asian Populations: A Narrative Review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mazzotti DR et al. (2025). Tirzepatide, Mortality, Cardiovascular, and Renal Outcomes in Sleep Apnea: Evidence… [PMID: 40935542]
Laboratory literature summary: Tirzepatide, Mortality, Cardiovascular, and Renal Outcomes in Sleep Apnea: Evidence From Real World Data. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Augusto SN Jr et al. (2025). Laboratory research record on GLP-2T [PMID: 39890046]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Natale R et al. (2025). Laboratory research record on GLP-2T [PMID: 41064709]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Alawaji R et al. (2025). Assessing the investigational potential of Tirzepatide in modulating inflammatory… [PMID: 41116319]
Laboratory literature summary: Assessing the investigational potential of Tirzepatide in modulating inflammatory responses and mitigating acute pancreatitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pantea I et al. (2026). Tirzepatide in Metabolically Dysfunctional-Associated Steatohepatitis (MASH): A… [PMID: 41964153]
Laboratory literature summary: Tirzepatide in Metabolically Dysfunctional-Associated Steatohepatitis (MASH): A Bibliometric and Evidence-Based Review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Manueli Laos EG et al. (2026). Impact of Tirzepatide research protocol on Thyroid Disease: Understanding Risks and… [PMID: 42145153]
Laboratory literature summary: Impact of Tirzepatide research protocol on Thyroid Disease: Understanding Risks and Emerging Insights. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mohammed GF et al. (2025). Tirzepatide Affect behavioral Function in research subjects: Case Report [PMID: 40487373]
Laboratory literature summary: Tirzepatide Affect behavioral Function in research subjects: Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kamrul-Hasan ABM et al. (2025). Neuropsychiatric Effects of Tirzepatide: A Systematic Review and Meta-Analysis [PMID: 39733942]
Laboratory literature summary: Neuropsychiatric Effects of Tirzepatide: A Systematic Review and Meta-Analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Panou T et al. (2026). Laboratory research record on GLP-2T [PMID: 42240053]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Dong S et al. (2026). Laboratory research record on GLP-2T [PMID: 41923370]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Chen CC et al. (2025). Revisiting Tirzepatide's Body Composition Model: Underestimated Fat-Free Mass Loss and… [PMID: 40888696]
Laboratory literature summary: Revisiting Tirzepatide's Body Composition Model: Underestimated Fat-Free Mass Loss and laboratory Implications. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Li X et al. (2026). People With Lowest Physical Functioning Scores Showed Greatest Improvement After… [PMID: 41187013]
Laboratory literature summary: People With Lowest Physical Functioning Scores Showed Greatest Improvement After Tirzepatide investigation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fontana RJ et al. (2024). First Report of Tirzepatide Hepatotoxicity with Jaundice [PMID: 38964597]
Laboratory literature summary: First Report of Tirzepatide Hepatotoxicity with Jaundice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pieber TR et al. (2025). Laboratory research record on GLP-2T [PMID: 40964167]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Novograd J et al. (2023). Tirzepatide for body-composition research: Can Medical research protocol "Outweigh"… [PMID: 36688833]
Laboratory literature summary: Tirzepatide for body-composition research: Can Medical research protocol "Outweigh" Bariatric Surgery?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
He Z et al. (2023). Tirzepatide-Induced Biphasic Anaphylactic Reaction: A Case Report [PMID: 38186543]
Laboratory literature summary: Tirzepatide-Induced Biphasic Anaphylactic Reaction: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Khan SU et al. (2025). Individual Variability in the Cardiometabolic Response to Tirzepatide: Moving Beyond… [PMID: 40368576]
Laboratory literature summary: Individual Variability in the Cardiometabolic Response to Tirzepatide: Moving Beyond the Average. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yen IW et al. (2026). Tirzepatide-induced body composition changes: Implications from the SURPASS-3 MRI substudy [PMID: 41482821]
Laboratory literature summary: Tirzepatide-induced body composition changes: Implications from the SURPASS-3 MRI substudy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Patoulias D et al. (2022). Updated Meta-Analysis Assessing the Cardiovascular observed endpoints of Tirzepatide [PMID: 35977865]
Laboratory literature summary: Updated Meta-Analysis Assessing the Cardiovascular observed endpoints of Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yu Z et al. (2026). Adverse events associated with tirzepatide: a focus on subgroup-specific differences [PMID: 41742317]
Laboratory literature summary: Adverse events associated with tirzepatide: a focus on subgroup-specific differences. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kassir R et al. (2025). Discontinuation of Tirzepatide and Semaglutide Prior to Gastric Sleeve Surgery:… [PMID: 40163291]
Laboratory literature summary: Discontinuation of Tirzepatide and Semaglutide Prior to Gastric Sleeve Surgery: laboratory Considerations and Guidelines. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Harris E (2024). Tirzepatide Lowered Blood Pressure in People With metabolic research models [PMID: 38381469]
Laboratory literature summary: Tirzepatide Lowered Blood Pressure in People With metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Katsura M et al. (2026). Laboratory research record on GLP-2T [PMID: 41891334]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Nolan T (2026). Maintaining body-composition research with tirzepatide… and other research [PMID: 42208988]
Laboratory literature summary: Maintaining body-composition research with tirzepatide… and other research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gisondi P et al. (2026). Laboratory research record on GLP-2T [PMID: 41239939]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Chen H et al. (2025). Post-marketing laboratory profile monitoring of tirzepatide: a pharmacovigilance study… [PMID: 40037695]
Laboratory literature summary: Post-marketing laboratory profile monitoring of tirzepatide: a pharmacovigilance study based on the FAERS database. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Terrington I et al. (2024). Idiosyncratic acute liver failure induced by Tirzepatide [PMID: 39733320]
Laboratory literature summary: Idiosyncratic acute liver failure induced by Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Belcourt J et al. (2026). Laboratory research record on GLP-2T [PMID: 41689811]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Zhang Y et al. (2025). Oral Delivery of Semaglutide and Tirzepatide Using Milk-Derived Small Extracellular… [PMID: 41293773]
Laboratory literature summary: Oral Delivery of Semaglutide and Tirzepatide Using Milk-Derived Small Extracellular Vesicles. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Scheen A (2025). [SURMOUNT-OSA study: tirzepatide improves obstructive sleep apnoea in research… [PMID: 40243250]
Laboratory literature summary: [SURMOUNT-OSA study: tirzepatide improves obstructive sleep apnoea in research subjects with metabolic research models]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nguyen T et al. (2023). Evaluating the observed endpoints and Pharmacoeconomics of Semaglutide and Tirzepatide… [PMID: 37449929]
Laboratory literature summary: Evaluating the observed endpoints and Pharmacoeconomics of Semaglutide and Tirzepatide in the Setting of metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sonavane K et al. (2025). Rhabdomyolysis Associated with the Use of Tirzepatide [PMID: 40352714]
Laboratory literature summary: Rhabdomyolysis Associated with the Use of Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chen SC et al. (2026). Neuropsychiatric Outcomes With Tirzepatide, Semaglutide, and Other GLP-1 Receptor Agonists [PMID: 42420795]
Laboratory literature summary: Neuropsychiatric Outcomes With Tirzepatide, Semaglutide, and Other GLP-1 Receptor Agonists. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shang R et al. (2025). Cardioprotective effects of a 'twincretin' drug tirzepatide in heart failure following… [PMID: 39902650]
Laboratory literature summary: Cardioprotective effects of a 'twincretin' drug tirzepatide in heart failure following myocardial infarction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ren L et al. (2026). Tirzepatide Regulates Pacemaker Function by Modulating cAMP and Calcium Dynamics in… [PMID: 42330097]
Laboratory literature summary: Tirzepatide Regulates Pacemaker Function by Modulating cAMP and Calcium Dynamics in research subjects Sinoatrial Node Cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Belcourt J et al. (2025). Bypassing Prescribers and Pharmacists: Online Purchasing of Semaglutide and… [PMID: 39285774]
Laboratory literature summary: Bypassing Prescribers and Pharmacists: Online Purchasing of Semaglutide and Tirzepatide "For Research Purposes". Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hitaka K et al. (2026). Observed endpoints of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide… [PMID: 41723268]
Laboratory literature summary: observed endpoints of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide on MC4R deficient metabolic research models and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sood A et al. (2024). Laboratory research record on GLP-2T [PMID: 38265050]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Pang ZJ et al. (2025). Hydrophobic Tag-Assisted Liquid-Phase Synthesis of Tirzepatide [PMID: 40928256]
Laboratory literature summary: Hydrophobic Tag-Assisted Liquid-Phase Synthesis of Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mihălțan FD et al. (2026). Tirzepatide in metabolic research models-Related Obstructive Sleep Apnea: Beyond… [PMID: 42195357]
Laboratory literature summary: Tirzepatide in metabolic research models-Related Obstructive Sleep Apnea: Beyond body-composition research Toward Disease Modification?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ahern S (2025). Allodynia and Dysesthesia Associated With Semaglutide and Tirzepatide [PMID: 41210042]
Laboratory literature summary: Allodynia and Dysesthesia Associated With Semaglutide and Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shinde S et al. (2026). Research subjects' Experiences of Obstructive Sleep Apnea and Tirzepatide… [PMID: 41793578]
Laboratory literature summary: research subjects' Experiences of Obstructive Sleep Apnea and Tirzepatide investigation: An Exit Interview Study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Thiriveedi M et al. (2026). A narrative review on tirzepatide's investigational potential in glycemic control and… [PMID: 41496949]
Laboratory literature summary: A narrative review on tirzepatide's investigational potential in glycemic control and cardioprotection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Martín Correa E et al. (2025). [Arthritis secondary to tirzepatide. Case report] [PMID: 40513494]
Laboratory literature summary: [Arthritis secondary to tirzepatide. Case report]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rabbani SA et al. (2024). Laboratory research record on GLP-2T [PMID: 39194153]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Rosenstock J et al. (2023). Achieving Normoglycemia With Tirzepatide: Analysis of SURPASS 1-4 Trials [PMID: 37673061]
Laboratory literature summary: Achieving Normoglycemia With Tirzepatide: Analysis of SURPASS 1-4 Trials. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nguyen E et al. (2026). Hypercalcemia Induced by Tirzepatide and Calcium Supplementation: A Case Report [PMID: 42226819]
Laboratory literature summary: Hypercalcemia Induced by Tirzepatide and Calcium Supplementation: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Al Zweihary AM (2024). Laboratory research record on GLP-2T [PMID: 38322055]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Trocchio LL et al. (2026). Taking back control: The experience of adults using semaglutide and tirzepatide for… [PMID: 41399811]
Laboratory literature summary: Taking back control: The experience of adults using semaglutide and tirzepatide for metabolic research models investigation – A…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Roche E et al. (2025). Laboratory research record on GLP-2T [PMID: 40471291]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Simental-Mendía LE et al. (2024). Effect of tirzepatide on leptin and adiponectin levels [PMID: 39089971]
Laboratory literature summary: Effect of tirzepatide on leptin and adiponectin levels. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tucker JM et al. (2024). The Tirzepatide Drop: Beware of Slimmer's Paralysis [PMID: 39051436]
Laboratory literature summary: The Tirzepatide Drop: Beware of Slimmer's Paralysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jung HN et al. (2022). The Upcoming Weekly Tides (Semaglutide vs. Tirzepatide) against metabolic research… [PMID: 35314521]
Laboratory literature summary: The Upcoming Weekly Tides (Semaglutide vs. Tirzepatide) against metabolic research models: STEP or SURPASS?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dan K et al. (2026). Early intervention with tirzepatide or semaglutide influences anti-atherosclerotic… [PMID: 41946762]
Laboratory literature summary: Early intervention with tirzepatide or semaglutide influences anti-atherosclerotic effects in ApoE knockout mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Caporusso M et al. (2025). Observed endpoints and laboratory profile of Tirzepatide in Refractory Hypoglycemia… [PMID: 41140513]
Laboratory literature summary: observed endpoints and laboratory profile of Tirzepatide in Refractory Hypoglycemia Associated with Esophagojejunostomy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tayyaba et al. (2023). Laboratory research record on GLP-2T [PMID: 37218275]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Alawad AO et al. (2026). Beyond glycemic control: laboratory cardiovascular effects of tirzepatide-a narrative… [PMID: 42534427]
Laboratory literature summary: Beyond glycemic control: laboratory cardiovascular effects of tirzepatide-a narrative review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hedge ET et al. (2025). Exacerbation of Postural Orthostatic Tachycardia Syndrome With Tirzepatide Prescribed… [PMID: 40944681]
Laboratory literature summary: Exacerbation of Postural Orthostatic Tachycardia Syndrome With Tirzepatide Prescribed for body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Murugadoss K et al. (2026). Laboratory research record on GLP-2T [PMID: 42163990]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Di Odoardo LAF et al. (2025). Metabolic research models update: cardiovascular risk and investigational innovations… [PMID: 40248309]
Laboratory literature summary: metabolic research models update: cardiovascular risk and investigational innovations (focus on semaglutide and tirzepatide). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Habiba U et al. (2023). Tirzepatide – A major breakthrough in the fight against metabolic research models [PMID: 36932808]
Laboratory literature summary: Tirzepatide – A major breakthrough in the fight against metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chuan F et al. (2026). Understanding Weight Regain After Tirzepatide Withdrawal [PMID: 42043833]
Laboratory literature summary: Understanding Weight Regain After Tirzepatide Withdrawal. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Santulli G (2022). Laboratory research record on GLP-2T [PMID: 35172066]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Patoulias D et al. (2022). Laboratory research record on GLP-2T [PMID: 35172065]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Solini A (2022). Tirzepatide and kidney function: an intriguing and promising observation [PMID: 36152638]
Laboratory literature summary: Tirzepatide and kidney function: an intriguing and promising observation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Moura FA et al. (2022). Laboratory research record on GLP-2T [PMID: 35260841]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Welberg L (2025). Tirzepatide affects NAc activity and food preoccupation [PMID: 41339983]
Laboratory literature summary: Tirzepatide affects NAc activity and food preoccupation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Anderer S (2025). Tirzepatide Outperforms Semaglutide in Head-to-Head metabolic research models Trial [PMID: 40478570]
Laboratory literature summary: Tirzepatide Outperforms Semaglutide in Head-to-Head metabolic research models Trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Packer M et al. (2025). Tirzepatide for Heart Failure and metabolic research models. Reply [PMID: 40267440]
Laboratory literature summary: Tirzepatide for Heart Failure and metabolic research models. Reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hoffmann K et al. (2026). Laboratory research record on GLP-2T [PMID: 41200927]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Rebitch CB (2023). Laboratory research record on GLP-2T [PMID: 37440749]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Khan I et al. (2026). Tirzepatide as a multi-organ integrator in metabolic diseases: a review of molecular… [PMID: 42387035]
Laboratory literature summary: Tirzepatide as a multi-organ integrator in metabolic diseases: a review of molecular mechanisms and laboratory translation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Strollo F et al. (2024). Laboratory research record on GLP-2T [PMID: 39085745]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Dziewierz A et al. (2026). Superior Cerebrovascular Outcomes with Tirzepatide Versus Semaglutide: A Call for… [PMID: 41075125]
Laboratory literature summary: Superior Cerebrovascular Outcomes with Tirzepatide Versus Semaglutide: A Call for Cautious Interpretation of Observational Data. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mahase E (2023). Laboratory research record on GLP-2T [PMID: 37696547]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wang L (2022). Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between… [PMID: 35651477]
Laboratory literature summary: Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Seo M et al. (2026). Persistent Adipose Inflammation Despite Metabolic Recovery Reveals Tissue-Specific… [PMID: 42136381]
Laboratory literature summary: Persistent Adipose Inflammation Despite Metabolic Recovery Reveals Tissue-Specific Immunomodulation by Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Spaeth LD et al. (2026). Tirzepatide-Induced Liver Injury: A Rare Complication [PMID: 41938310]
Laboratory literature summary: Tirzepatide-Induced Liver Injury: A Rare Complication. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhao L et al. (2024). Laboratory research record on GLP-2T [PMID: 39602185]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Chen Z et al. (2024). Laboratory research record on GLP-2T [PMID: 39602179]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Decker SRR et al. (2026). Laboratory research record on GLP-2T [PMID: 41348220]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Brown A et al. (2026). Real-World Effectiveness of Semaglutide and Tirzepatide Compared With Bariatric Surgery [PMID: 42345739]
Laboratory literature summary: Real-World Effectiveness of Semaglutide and Tirzepatide Compared With Bariatric Surgery. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sattar N et al. (2026). Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed… [PMID: 41940793]
Laboratory literature summary: Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed control arm Analysis of REWIND. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cadena-Ullauri S et al. (2026). Tirzepatide and the gut microbiota-metabolic research models axis: metabolic… [PMID: 42499664]
Laboratory literature summary: Tirzepatide and the gut microbiota-metabolic research models axis: metabolic mechanisms and investigational perspectives. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Frías JP et al. (2022). Laboratory research record on GLP-2T [PMID: 35172067]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Aronne LJ et al. (2024). Laboratory research record on GLP-2T [PMID: 38630499]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Xiao Y et al. (2024). Laboratory research record on GLP-2T [PMID: 38630501]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Duncan J et al. (2026). Laboratory research record on GLP-2T [PMID: 41438798]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
La Vignera S et al. (2026). Unconventional Applications of Semaglutide and Tirzepatide: From Oncology to research… [PMID: 42512116]
Laboratory literature summary: Unconventional Applications of Semaglutide and Tirzepatide: From Oncology to research subjects Reproduction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kim H et al. (2025). Comparative analysis of LJ-4378 and tirzepatide in mouse models of metabolic research… [PMID: 41199017]
Laboratory literature summary: Comparative analysis of LJ-4378 and tirzepatide in mouse models of metabolic research models and weight regain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Do D et al. (2026). Laboratory research record on GLP-2T [PMID: 41576595]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Colorado M et al. (2025). Unanticipated Adverse Events With Tirzepatide: Three Cases Underscoring the Importance… [PMID: 40895495]
Laboratory literature summary: Unanticipated Adverse Events With Tirzepatide: Three Cases Underscoring the Importance of Postmarketing Monitoring. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bhusal A (2023). Laboratory research record on GLP-2T [PMID: 36845823]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Bahdi F et al. (2025). Revisional endoscopic sleeve gastroplasty versus semaglutide and tirzepatide for… [PMID: 39909715]
Laboratory literature summary: Revisional endoscopic sleeve gastroplasty versus semaglutide and tirzepatide for weight recidivism after sleeve gastrectomy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Herrera HO et al. (2026). Risk of new-onset hair loss with semaglutide and tirzepatide: A TriNetX cohort study [PMID: 41707704]
Laboratory literature summary: Risk of new-onset hair loss with semaglutide and tirzepatide: A TriNetX cohort study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Neumann J et al. (2025). Tirzepatide increased force of contraction in the isolated research subjects atrium [PMID: 40299022]
Laboratory literature summary: Tirzepatide increased force of contraction in the isolated research subjects atrium. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kaul S (2026). On the Noninferiority of Tirzepatide: Insights From SURPASS-CVOT [PMID: 42233554]
Laboratory literature summary: On the Noninferiority of Tirzepatide: Insights From SURPASS-CVOT. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Heerspink HJL et al. (2026). Association of Tirzepatide With Kidney Parameters in Participants With metabolic… [PMID: 41796090]
Laboratory literature summary: Association of Tirzepatide With Kidney Parameters in Participants With metabolic research models and Prediabetes From SURMOUNT-1 Over…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
O Mandour M et al. (2026). Evaluating the investigational impact of tirzepatide in people with partial lipodystrophy [PMID: 41866320]
Laboratory literature summary: Evaluating the investigational impact of tirzepatide in people with partial lipodystrophy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rodriguez PJ et al. (2025). Semaglutide vs Tirzepatide Dosages for body-composition research-Reply [PMID: 39585685]
Laboratory literature summary: Semaglutide vs Tirzepatide Dosages for body-composition research-Reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Levy ME et al. (2025). Semaglutide vs Tirzepatide Dosages for body-composition research [PMID: 39585682]
Laboratory literature summary: Semaglutide vs Tirzepatide Dosages for body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chin SY et al. (2025). Methodological considerations in tirzepatide-bariatric surgery comparative study [PMID: 41057114]
Laboratory literature summary: Methodological considerations in tirzepatide-bariatric surgery comparative study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Borlaug BA et al. (2026). Effects of Tirzepatide in metabolic research models-Related HFpEF by Sex: A… [PMID: 42417681]
Laboratory literature summary: Effects of Tirzepatide in metabolic research models-Related HFpEF by Sex: A Prespecified Secondary Analysis From the SUMMIT Trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tan TM et al. (2021). Laboratory research record on GLP-2T [PMID: 34186023]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Abbasi J (2023). Laboratory research record on GLP-2T [PMID: 37966831]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Scheen A et al. (2026). Laboratory research record on GLP-2T [PMID: 41815032]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Sawamura T et al. (2026). Laboratory research record on GLP-2T [PMID: 40803851]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Hussein MH et al. (2026). Response To "Superior Cerebrovascular Outcomes with Tirzepatide Versus Semaglutide: A… [PMID: 41317265]
Laboratory literature summary: Response To "Superior Cerebrovascular Outcomes with Tirzepatide Versus Semaglutide: A Call for Cautious Interpretation of Observational…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2025). Laboratory research record on GLP-2T [PMID: 40461177]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Anderer S (2025). Laboratory research record on GLP-2T [PMID: 40314963]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Nikitin D et al. (2022). Laboratory research record on GLP-2T [PMID: 35621725]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Liuzzo G et al. (2024). Weekly Journal Scan: tirzepatide SURMOUNTs metabolic research models-related… [PMID: 39302811]
Laboratory literature summary: Weekly Journal Scan: tirzepatide SURMOUNTs metabolic research models-related obstructive sleep apnoea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Moyad MA (2023). Embracing the Pros and Cons of the New body-composition research Medications… [PMID: 37659049]
Laboratory literature summary: Embracing the Pros and Cons of the New body-composition research Medications (Semaglutide, Tirzepatide, Etc.). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Di Guardo A (2026). Accidental intradermal parenteral-route administration of tirzepatide associated with… [PMID: 42507846]
Laboratory literature summary: Accidental intradermal parenteral-route administration of tirzepatide associated with increased adverse events. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Seetharaman R et al. (2023). The prospective record-breaking metabolic research models drug tirzepatide raises… [PMID: 37326670]
Laboratory literature summary: The prospective record-breaking metabolic research models drug tirzepatide raises concerns about affordability. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Li Z et al. (2026). Tirzepatide attenuates doxorubicin-induced cardiotoxicity via mitochondrial function… [PMID: 42180982]
Laboratory literature summary: Tirzepatide attenuates doxorubicin-induced cardiotoxicity via mitochondrial function improvement. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nasim MT et al. (2023). The Potential body-composition research Benefits Of Tirzepatide: A Double-Edged Sword? [PMID: 38013572]
Laboratory literature summary: The Potential body-composition research Benefits Of Tirzepatide: A Double-Edged Sword?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Busti M et al. (2026). Tirzepatide versus dulaglutide in heart failure: another SURPASS attempt yielding a tie [PMID: 41984352]
Laboratory literature summary: Tirzepatide versus dulaglutide in heart failure: another SURPASS attempt yielding a tie. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cao CY et al. (2026). Drug-induced liver injury secondary to tirzepatide [PMID: 41932719]
Laboratory literature summary: Drug-induced liver injury secondary to tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fareed A et al. (2025). Charting New Territories in metabolic research models Management- Traditional… [PMID: 39278353]
Laboratory literature summary: Charting New Territories in metabolic research models Management- Traditional Techniques to Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Alqarni B et al. (2026). Acute liver injury associated with tirzepatide: An unexpected adverse event warranting… [PMID: 41519257]
Laboratory literature summary: Acute liver injury associated with tirzepatide: An unexpected adverse event warranting laboratory attention. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Centor RM et al. (2026). Web Exclusive. Annals On Call – Dulaglutide, Semaglutide, and Tirzepatide: How Do… [PMID: 41554140]
Laboratory literature summary: Web Exclusive. Annals On Call – Dulaglutide, Semaglutide, and Tirzepatide: How Do Gastrointestinal Adverse Effects Compare?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bailey CJ (2021). Tirzepatide: a new low for bodyweight and blood glucose [PMID: 34419226]
Laboratory literature summary: Tirzepatide: a new low for bodyweight and blood glucose. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Seetharaman R (2023). Effect of tirzepatide on prediabetics and blood pressure with implications for future… [PMID: 36607902]
Laboratory literature summary: Effect of tirzepatide on prediabetics and blood pressure with implications for future research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Takebayashi K et al. (2026). Acute onset of neovascular age-related macular degeneration after initiation of… [PMID: 41948417]
Laboratory literature summary: Acute onset of neovascular age-related macular degeneration after initiation of tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Huang YN et al. (2026). Laboratory research record on GLP-2T [PMID: 42373755]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Morgenthaler L et al. (2024). Laboratory research record on GLP-2T [PMID: 39700350]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Popovic DS et al. (2024). Laboratory research record on GLP-2T [PMID: 38456523]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wilkinson E (2024). NICE recommendations on tirzepatide for body-composition research could increase NHS… [PMID: 38839081]
Laboratory literature summary: NICE recommendations on tirzepatide for body-composition research could increase NHS access. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Guan R et al. (2023). Prediction of pediatric exposure level of tirzepatide from the reference adult… [PMID: 38089044]
Laboratory literature summary: Prediction of pediatric exposure level of tirzepatide from the reference adult exposure level using physiologically based…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ma J et al. (2025). Tirzepatide administration improves cognitive impairment in HFD mice by regulating the… [PMID: 39222203]
Laboratory literature summary: Tirzepatide administration improves cognitive impairment in HFD mice by regulating the SIRT3-NLRP3 axis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Slomski A (2021). Laboratory research record on GLP-2T [PMID: 34427602]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Slomski A (2021). Laboratory research record on GLP-2T [PMID: 34962528]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Howard T et al. (2026). Papular granuloma annulare associated with tirzepatide: A case report [PMID: 42499401]
Laboratory literature summary: Papular granuloma annulare associated with tirzepatide: A case report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Patoulias D et al. (2024). Laboratory research record on GLP-2T [PMID: 38151420]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Nejat C et al. (2026). Hypersensitivity Reaction to Tirzepatide With Demonstrated Tolerance to Semaglutide: A… [PMID: 42487660]
Laboratory literature summary: Hypersensitivity Reaction to Tirzepatide With Demonstrated Tolerance to Semaglutide: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ortega H et al. (2025). Laboratory research record on GLP-2T [PMID: 40900412]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Mullard A (2022). Laboratory research record on GLP-2T [PMID: 35596075]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Davies C (2025). Laboratory research record on GLP-2T [PMID: 40383978]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Ruder K (2024). At ObesityWeek, More Data and Questions About Semaglutide, Tirzepatide, and Retatrutide [PMID: 38055301]
Laboratory literature summary: At ObesityWeek, More Data and Questions About Semaglutide, Tirzepatide, and Retatrutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Alathary A et al. (2025). Tirzepatide research protocol counters inflammatory and apoptotic responses induced by… [PMID: 40367464]
Laboratory literature summary: Tirzepatide research protocol counters inflammatory and apoptotic responses induced by high-fat diet in rat liver. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ryan DH (2021). Next Generation Antiobesity Medications: Setmelanotide, Semaglutide, Tirzepatide and… [PMID: 34518444]
Laboratory literature summary: Next Generation Antiobesity Medications: Setmelanotide, Semaglutide, Tirzepatide and Bimagrumab: What do They Mean for laboratory Practice?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
El Ghandour S et al. (2025). Laboratory research record on GLP-2T [PMID: 40033710]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wells DA et al. (2026). Probable Tirzepatide-Induced Rhabdomyolysis in an HIV-Positive research subjects [PMID: 41756106]
Laboratory literature summary: Probable Tirzepatide-Induced Rhabdomyolysis in an HIV-Positive research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Iqbal S et al. (2026). A Case of Severe Hypercalcemia in a research subjects Taking Tirzepatide: Potential… [PMID: 42504310]
Laboratory literature summary: A Case of Severe Hypercalcemia in a research subjects Taking Tirzepatide: Potential Risk Factors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wise J (2024). Tirzepatide: metabolic research models parenteral-route administration will get phased… [PMID: 39638348]
Laboratory literature summary: Tirzepatide: metabolic research models parenteral-route administration will get phased rollout to avoid overwhelming GPs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Phox M et al. (2025). Tirzepatide-Induced Liver Injury: A Rare Medication Side Effect [PMID: 40212859]
Laboratory literature summary: Tirzepatide-Induced Liver Injury: A Rare Medication Side Effect. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rojas K et al. (2026). A Rare Case of Tirzepatide-Associated Immune Thrombocytopenia [PMID: 41909371]
Laboratory literature summary: A Rare Case of Tirzepatide-Associated Immune Thrombocytopenia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gandhi GY (2021). Laboratory research record on GLP-2T [PMID: 34724396]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Lechner B et al. (2026). Laboratory research record on GLP-2T [PMID: 42538551]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Ebell MH (2025). Laboratory research record on GLP-2T [PMID: 40238986]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Tavosanis A (2025). Laboratory research record on GLP-2T [PMID: 39753978]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Powell J et al. (2024). Laboratory research record on GLP-2T [PMID: 38310052]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Harris E (2024). EHR Data Suggest Tirzepatide Outdoes Semaglutide for body-composition research [PMID: 39093576]
Laboratory literature summary: EHR Data Suggest Tirzepatide Outdoes Semaglutide for body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Limb M (2024). NHS England consults on rolling out metabolic research models parenteral-route… [PMID: 39366704]
Laboratory literature summary: NHS England consults on rolling out metabolic research models parenteral-route administration tirzepatide to meet demand. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hamidi H et al. (2024). Laboratory research record on GLP-2T [PMID: 39187147]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Zhan ZQ (2025). Tirzepatide and Autonomic Dysfunction: Insights From Postural Orthostatic Tachycardia… [PMID: 41945548]
Laboratory literature summary: Tirzepatide and Autonomic Dysfunction: Insights From Postural Orthostatic Tachycardia Syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chiu N et al. (2022). Laboratory research record on GLP-2T [PMID: 35929468]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Huo Y et al. (2025). Data mining study on adverse events of tirzepatide based on FAERS database [PMID: 39007672]
Laboratory literature summary: Data mining study on adverse events of tirzepatide based on FAERS database. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Singh G et al. (2026). Tirzepatide: A Breakthrough research protocol for Obstructive Sleep Apnea and… [PMID: 41140212]
Laboratory literature summary: Tirzepatide: A Breakthrough research protocol for Obstructive Sleep Apnea and Metabolic Dysfunction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dobriceanu RC et al. (2026). Laboratory research record on GLP-2T [PMID: 42510916]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Xu H et al. (2026). Laboratory research record on GLP-2T [PMID: 41985145]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
van Bruggen F (2026). Laboratory research record on GLP-2T [PMID: 41985144]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Becattini C et al. (2026). Laboratory research record on GLP-2T [PMID: 41985143]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Chuan F et al. (2026). Laboratory research record on GLP-2T [PMID: 41985142]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Anker MS et al. (2026). Laboratory research record on GLP-2T [PMID: 41985146]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Mady R et al. (2026). Laboratory research record on GLP-2T [PMID: 42388957]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Li J et al. (2026). Laboratory research record on GLP-2T [PMID: 42002077]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Kukanti C et al. (2025). Tirzepatide for Obstructive Sleep Apnea: A Novel investigational Promise and the… [PMID: 40420878]
Laboratory literature summary: Tirzepatide for Obstructive Sleep Apnea: A Novel investigational Promise and the Perioperative Considerations. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Clift AK et al. (2025). Tirzepatide in the NHS: The known unknowns of investigating metabolic research models… [PMID: 40197843]
Laboratory literature summary: Tirzepatide in the NHS: The known unknowns of investigating metabolic research models at a national scale. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Stortz E et al. (2024). Tirzepatide Improves Early Dumping Syndrome and Glucose Nadir in Postbariatric… [PMID: 39444516]
Laboratory literature summary: Tirzepatide Improves Early Dumping Syndrome and Glucose Nadir in Postbariatric Hypoglycemia After Sleeve Gastrectomy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ceesay OI et al. (2026). Abrupt Smoking Cessation Due to Sensory Aversion Following Tirzepatide Initiation [PMID: 42530904]
Laboratory literature summary: Abrupt Smoking Cessation Due to Sensory Aversion Following Tirzepatide Initiation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Liuzzo G et al. (2024). Weekly journal scan: SURMOUNTing body weight regain with tirzepatide after successful… [PMID: 38365916]
Laboratory literature summary: Weekly journal scan: SURMOUNTing body weight regain with tirzepatide after successful lifestyle intervention. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Khoo B et al. (2021). Laboratory research record on GLP-2T [PMID: 34672968]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Paneni F et al. (2021). Laboratory research record on GLP-2T [PMID: 34724707]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Morrissette K et al. (2024). Improvement of Recalcitrant Folliculitis Decalvans With Tirzepatide: A Case Report [PMID: 39845205]
Laboratory literature summary: Improvement of Recalcitrant Folliculitis Decalvans With Tirzepatide: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wang J et al. (2022). Mechanistic Study of Diketopiperazine Formation during Solid-Phase Peptide Synthesis… [PMID: 36570276]
Laboratory literature summary: Mechanistic Study of Diketopiperazine Formation during Solid-Phase Peptide Synthesis of Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Malapati SN (2025). Tirzepatide and Hydrochlorothiazide Coadministration in CKD: A Real-World Signal for… [PMID: 40748859]
Laboratory literature summary: Tirzepatide and Hydrochlorothiazide Coadministration in CKD: A Real-World Signal for Hypercalcemia Risk. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Galasso M et al. (2026). Tirzepatide as a investigational tool for kidney impairment in metabolic research… [PMID: 42464302]
Laboratory literature summary: Tirzepatide as a investigational tool for kidney impairment in metabolic research models: insights from a real-world study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shloush M et al. (2026). Laboratory research record on GLP-2T [PMID: 41945627]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Adam S et al. (2025). Exploring Adults' Experiences with Tirzepatide for body-composition research: A… [PMID: 41373319]
Laboratory literature summary: Exploring Adults' Experiences with Tirzepatide for body-composition research: A Mixed-Methods Study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Majid M et al. (2025). Cardiovascular benefits of Tirzepatide: A breakthrough in cardio-metabolic care [PMID: 40500849]
Laboratory literature summary: Cardiovascular benefits of Tirzepatide: A breakthrough in cardio-metabolic care. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Samajdar SS et al. (2026). Dulaglutide in the era of tirzepatide and semaglutide: reaffirming its role in… [PMID: 42256584]
Laboratory literature summary: Dulaglutide in the era of tirzepatide and semaglutide: reaffirming its role in contemporary cardiometabolic care. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sweiss H et al. (2025). Laboratory profile and Effectiveness of Tirzepatide in Solid-Organ Transplant Recipients [PMID: 40823610]
Laboratory literature summary: laboratory profile and Effectiveness of Tirzepatide in Solid-Organ Transplant Recipients. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gordon ER et al. (2024). Investigation of insulin resistance with tirzepatide leading to improvement of hair loss [PMID: 39135763]
Laboratory literature summary: investigation of insulin resistance with tirzepatide leading to improvement of hair loss. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ishimura A et al. (2024). Effect of switching from dulaglutide to tirzepatide on blood glucose and renal function [PMID: 39462543]
Laboratory literature summary: Effect of switching from dulaglutide to tirzepatide on blood glucose and renal function. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sun L et al. (2025). Laboratory research record on GLP-2T [PMID: 41389087]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Cosentino N et al. (2026). Laboratory research record on GLP-2T [PMID: 41983524]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Talha M et al. (2025). Prospecting the use of tirzepatide in combating metabolic research models in Pakistan [PMID: 41418149]
Laboratory literature summary: Prospecting the use of tirzepatide in combating metabolic research models in Pakistan. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Carmichael C et al. (2025). Laboratory research record on GLP-2T [PMID: 39987302]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Hayashi M et al. (2025). Acute Duodenal Ulcer Perforation Following Tirzepatide investigation: A Case Report [PMID: 40236372]
Laboratory literature summary: Acute Duodenal Ulcer Perforation Following Tirzepatide investigation: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ahmad A et al. (2026). Tirzepatide a major breakthrough in investigation of obstructive sleep apnoea [PMID: 42017745]
Laboratory literature summary: Tirzepatide a major breakthrough in investigation of obstructive sleep apnoea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bhandari P et al. (2026). Laboratory research record on GLP-2T [PMID: 42438627]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Mudd MK et al. (2025). Mental Health Effects of Tirzepatide: A Report of 2 research subjects [PMID: 40650872]
Laboratory literature summary: Mental Health Effects of Tirzepatide: A Report of 2 research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Heerspink HJL et al. (2025). Authors' Reply: Tirzepatide and Kidney Protection in metabolic research models:… [PMID: 40960873]
Laboratory literature summary: Authors' Reply: Tirzepatide and Kidney Protection in metabolic research models: Unanswered Questions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Anderer S (2025). FDA Approves Tirzepatide as First Drug for Obstructive Sleep Apnea [PMID: 39853991]
Laboratory literature summary: FDA Approves Tirzepatide as First Drug for Obstructive Sleep Apnea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wise J (2025). GPs can prescribe tirzepatide to priority research subjects groups from June [PMID: 40174951]
Laboratory literature summary: GPs can prescribe tirzepatide to priority research subjects groups from June. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chan LJ et al. (2024). A case of recalcitrant hidradenitis suppurativa concomitantly studied with tirzepatide [PMID: 39319185]
Laboratory literature summary: A case of recalcitrant hidradenitis suppurativa concomitantly studied with tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Soomro AM (2025). Can tirzepatide transform HFpEF management in Pakistan? A call for action [PMID: 41378422]
Laboratory literature summary: Can tirzepatide transform HFpEF management in Pakistan? A call for action. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Guerdjikova AI et al. (2025). Relapse in Anorexia Nervosa Associated With Tirzepatide: A Case Report [PMID: 40132115]
Laboratory literature summary: Relapse in Anorexia Nervosa Associated With Tirzepatide: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shi Y (2026). Tirzepatide and metabolic surgery: complementary approaches for multimodal management… [PMID: 41258966]
Laboratory literature summary: Tirzepatide and metabolic surgery: complementary approaches for multimodal management of MASLD. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Guth MA (2025). Laboratory research record on GLP-2T [PMID: 39921911]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Baretić M (2025). Laboratory research record on GLP-2T [PMID: 40607933]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Mansour NM et al. (2024). White analytical insight for sensitive fluorescent determination of semaglutide and… [PMID: 38508074]
Laboratory literature summary: White analytical insight for sensitive fluorescent determination of semaglutide and tirzepatide in pharmaceuticals and biological matrices. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Poloni A et al. (2025). Drug-drug interactions between tirzepatide and antiretrovirals: time to reassess and… [PMID: 40674289]
Laboratory literature summary: Drug-drug interactions between tirzepatide and antiretrovirals: time to reassess and reassure?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nauck MA et al. (2025). Promising investigation options with tirzepatide for Japanese individuals with… [PMID: 40031942]
Laboratory literature summary: Promising investigation options with tirzepatide for Japanese individuals with metabolic research models disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Almutairi HM et al. (2026). The lack of observed endpoints of tirzepatide in mitigating cisplatin-induced… [PMID: 41625437]
Laboratory literature summary: The lack of observed endpoints of tirzepatide in mitigating cisplatin-induced neurotoxicity and cognitive impairment in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mullard A (2025). Lilly's tirzepatide and Novo Nordisk's semaglutide vie for top drug spot [PMID: 41199002]
Laboratory literature summary: Lilly's tirzepatide and Novo Nordisk's semaglutide vie for top drug spot. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wu JY et al. (2026). Laboratory impact of tirzepatide on research subjects with chronic obstructive… [PMID: 42244870]
Laboratory literature summary: laboratory impact of tirzepatide on research subjects with chronic obstructive pulmonary disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Patarroyo-Rodriguez L et al. (2026). Tirzepatide-Associated Lithium Toxicity Necessitating Hemodialysis in Previously… [PMID: 42227267]
Laboratory literature summary: Tirzepatide-Associated Lithium Toxicity Necessitating Hemodialysis in Previously Stable Bipolar I Disorder. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sawamura T et al. (2025). Impacts of tirzepatide on older research subjects with diminished β-cell function and… [PMID: 40001315]
Laboratory literature summary: Impacts of tirzepatide on older research subjects with diminished β-cell function and dementia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Monjur MR (2026). Laboratory research record on GLP-2T [PMID: 41902340]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Pavlik V et al. (2026). Effect of tirzepatide on body weight in Czech soldiers [PMID: 40750116]
Laboratory literature summary: Effect of tirzepatide on body weight in Czech soldiers. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nicholls SJ et al. (2026). Laboratory research record on GLP-2T [PMID: 41985147]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Guerdjikova AI et al. (2026). Improvement of Compulsive Shopping on Tirzepatide: A Case Report [PMID: 41632102]
Laboratory literature summary: Improvement of Compulsive Shopping on Tirzepatide: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bitar Z et al. (2024). Exploring Hypoglycemic Ketoacidosis in Nondiabetic research subjects on Tirzepatide:… [PMID: 39686534]
Laboratory literature summary: Exploring Hypoglycemic Ketoacidosis in Nondiabetic research subjects on Tirzepatide: Is Starvation the Culprit?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bernardo ME et al. (2026). Laboratory research record on GLP-2T [PMID: 41768861]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Vignarajah A et al. (2026). Tirzepatide and Cardiovascular Outcomes in research subjects With Ventricular… [PMID: 41231182]
Laboratory literature summary: Tirzepatide and Cardiovascular Outcomes in research subjects With Ventricular Tachycardia and Systolic Heart Failure. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
De Fano M et al. (2026). Laboratory research record on GLP-2T [PMID: 42304199]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Khan S et al. (2026). Pharmacological progress in metabolic research models: tirzepatide's rising advantage… [PMID: 41497097]
Laboratory literature summary: Pharmacological progress in metabolic research models: tirzepatide's rising advantage over semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shiau BW et al. (2026). Laboratory benefits of tirzepatide in research subjects with steatotic liver disease… [PMID: 42373761]
Laboratory literature summary: laboratory benefits of tirzepatide in research subjects with steatotic liver disease and cardiometabolic dysfunction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lang K (2025). Laboratory research record on GLP-2T [PMID: 39900371]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Chigutsa E et al. (2025). Reply to "Revisiting Tirzepatide's Body Composition Model: Underestimated Fat-Free… [PMID: 40908596]
Laboratory literature summary: Reply to "Revisiting Tirzepatide's Body Composition Model: Underestimated Fat-Free Mass Loss and laboratory Implications". Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Salter A et al. (2026). Use of semaglutide and tirzepatide among people with multiple sclerosis [PMID: 42053291]
Laboratory literature summary: Use of semaglutide and tirzepatide among people with multiple sclerosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wen J et al. (2025). Association Between Semaglutide or Tirzepatide research protocol and Residual Gastric… [PMID: 41393547]
Laboratory literature summary: Association Between Semaglutide or Tirzepatide research protocol and Residual Gastric Content: A Potential Danger During Upper Endoscopy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ghusn W et al. (2026). Real-World Comparative Effectiveness of Tirzepatide and Semaglutide for metabolic… [PMID: 42383938]
Laboratory literature summary: Real-World Comparative Effectiveness of Tirzepatide and Semaglutide for metabolic research models: A Multicentered Study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ishimura A et al. (2025). Effects of research subjects age on the investigational effects of GIP/GLP-1 receptor… [PMID: 40301081]
Laboratory literature summary: Effects of research subjects age on the investigational effects of GIP/GLP-1 receptor agonists (tirzepatide). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
De Mattia G et al. (2025). The need to address the risk of osteosarcopenia induced by tirzepatide research protocol [PMID: 40556629]
Laboratory literature summary: The need to address the risk of osteosarcopenia induced by tirzepatide research protocol. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Grennan K et al. (2025). Fatal, Fulminant, Necrotizing Pancreatitis Associated With Recent Tirzepatide Initiation [PMID: 40270999]
Laboratory literature summary: Fatal, Fulminant, Necrotizing Pancreatitis Associated With Recent Tirzepatide Initiation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Serafini A et al. (2025). Laboratory research record on GLP-2T [PMID: 41176671]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Hidiroglu EE et al. (2026). Residual gastric content after tirzepatide discontinuation: is one week enough? [PMID: 42329593]
Laboratory literature summary: Residual gastric content after tirzepatide discontinuation: is one week enough?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chaudhury N et al. (2025). Laboratory research record on GLP-2T [PMID: 40408634]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Liao XC et al. (2026). Tirzepatide for weight and behavior management in a research subjects with… [PMID: 42245471]
Laboratory literature summary: Tirzepatide for weight and behavior management in a research subjects with Smith-Magenis syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bhullar H et al. (2026). Complete Skin Remission of Lichen Planus With Tirzepatide [PMID: 41979937]
Laboratory literature summary: Complete Skin Remission of Lichen Planus With Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shen P et al. (2026). Gastrointestinal adverse events associated with tirzepatide: A bibliometric and… [PMID: 41894422]
Laboratory literature summary: Gastrointestinal adverse events associated with tirzepatide: A bibliometric and pharmacovigilance analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Huang R et al. (2025). Outbreak of metabolic dysfunction-associated steatohepatitis pharmacotherapies in… [PMID: 39654450]
Laboratory literature summary: Outbreak of metabolic dysfunction-associated steatohepatitis pharmacotherapies in 2024: From resmetirom to tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Farooqi MF et al. (2024). Extensive Deep Vein Thrombosis in a Young Man Taking Tirzepatide for body-composition… [PMID: 39734498]
Laboratory literature summary: Extensive Deep Vein Thrombosis in a Young Man Taking Tirzepatide for body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Liu X et al. (2025). Coverage and Prior Authorization Policies for Semaglutide and Tirzepatide in Medicare… [PMID: 40880091]
Laboratory literature summary: Coverage and Prior Authorization Policies for Semaglutide and Tirzepatide in Medicare Part D Plans. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Han J et al. (2025). Cyclic Hydroxylamines for Native Residue-Forming Peptide Ligations: Synthesis of… [PMID: 40934092]
Laboratory literature summary: Cyclic Hydroxylamines for Native Residue-Forming Peptide Ligations: Synthesis of Ubiquitin and Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2025). Laboratory research record on GLP-2T [PMID: 39919809]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wentling J et al. (2025). Common peroneal neuropathy following significant body-composition research induced by… [PMID: 40391981]
Laboratory literature summary: Common peroneal neuropathy following significant body-composition research induced by tirzepatide research protocol. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Angelopoulos N et al. (2026). Short-term effect of tirzepatide on serum calcitonin in adults with metabolic research… [PMID: 42081121]
Laboratory literature summary: Short-term effect of tirzepatide on serum calcitonin in adults with metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dobashi H et al. (2025). Laboratory research record on GLP-2T [PMID: 40123805]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Fauchier L et al. (2026). Early cardiovascular-kidney-metabolic progression with tirzepatide: population… [PMID: 42155604]
Laboratory literature summary: Early cardiovascular-kidney-metabolic progression with tirzepatide: population definition and laboratory interpretation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Iskander M et al. (2025). Acute Functional Gastric Outlet Obstruction Associated With Low-exposure level Tirzepatide [PMID: 40026949]
Laboratory literature summary: Acute Functional Gastric Outlet Obstruction Associated With Low-exposure level Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Abbasi J (2026). Laboratory research record on GLP-2T [PMID: 41961515]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Castaneda R et al. (2026). Sex, Not Age, Predicts body-composition research Outcomes With Tirzepatide: A… [PMID: 42290037]
Laboratory literature summary: Sex, Not Age, Predicts body-composition research Outcomes With Tirzepatide: A Retrospective Analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Uyanık T (2026). Interpreting Lean Mass Changes During Tirzepatide-Induced body-composition research:… [PMID: 42115704]
Laboratory literature summary: Interpreting Lean Mass Changes During Tirzepatide-Induced body-composition research: Beyond Quantitative Metrics. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Caputo C (2026). Tirzepatide-associated hyponatremia in a research subjects with known arginine… [PMID: 42051284]
Laboratory literature summary: Tirzepatide-associated hyponatremia in a research subjects with known arginine vasopressin deficiency. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Taylor B et al. (2025). Diverticular Stricture and Hepatic Abscess Formation During Tirzepatide research… [PMID: 41393655]
Laboratory literature summary: Diverticular Stricture and Hepatic Abscess Formation During Tirzepatide research protocol for metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ebell MH (2025). Laboratory research record on GLP-2T [PMID: 40961318]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Louwagie EJ et al. (2025). Euglycemic Ketoacidosis Following Coadministration of an SGLT2 Inhibitor and Tirzepatide [PMID: 39949871]
Laboratory literature summary: Euglycemic Ketoacidosis Following Coadministration of an SGLT2 Inhibitor and Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Purvez A et al. (2025). New-Onset Atrial Fibrillation Potentially Associated With Tirzepatide: A Case Report [PMID: 41425685]
Laboratory literature summary: New-Onset Atrial Fibrillation Potentially Associated With Tirzepatide: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Azeem S et al. (2026). Vitreous hemorrhage in a research subjects on tirzepatide: Coincidence or drug induced? [PMID: 41929995]
Laboratory literature summary: Vitreous hemorrhage in a research subjects on tirzepatide: Coincidence or drug induced?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lodrigues AB et al. (2026). Micro Doses, Macro Potential? Considerations for Microdosing Tirzepatide in… [PMID: 42244165]
Laboratory literature summary: Micro Doses, Macro Potential? Considerations for Microdosing Tirzepatide in Multi-exposure level Pens. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Troshina EA et al. (2025). [A personalized, evidence-based approach to metabolic research models research… [PMID: 41640144]
Laboratory literature summary: [A personalized, evidence-based approach to metabolic research models research protocol using laboratory algorithms: semaglutide or…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Alqefari GB et al. (2026). Marked improvement in severe hidradenitis suppurativa following tirzepatide research… [PMID: 42369846]
Laboratory literature summary: Marked improvement in severe hidradenitis suppurativa following tirzepatide research protocol: a case report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Suresh Babu Y et al. (2025). Laboratory research record on GLP-2T [PMID: 41439084]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Deniz MS et al. (2026). Pityriasis Lichenoides et Varioliformis Acuta Associated With Tirzepatide: A First Report [PMID: 42307617]
Laboratory literature summary: Pityriasis Lichenoides et Varioliformis Acuta Associated With Tirzepatide: A First Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Angelopoulos N et al. (2026). Early changes in body composition with tirzepatide in adults with metabolic research… [PMID: 42275945]
Laboratory literature summary: Early changes in body composition with tirzepatide in adults with metabolic research models: a real-world BIA study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mady R et al. (2026). Laboratory research record on GLP-2T [PMID: 42388932]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Lin F et al. (2026). Correction: body-composition research efficiency and laboratory profile of… [PMID: 41926378]
Laboratory literature summary: Correction: body-composition research efficiency and laboratory profile of tirzepatide: A Systematic review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chakrabarti MP et al. (2026). Laboratory research record on GLP-2T [PMID: 42101979]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Eason K et al. (2025). Vicarious observed endpoints of tirzepatide in a cohabiting couple: An observational… [PMID: 41211573]
Laboratory literature summary: Vicarious observed endpoints of tirzepatide in a cohabiting couple: An observational case report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Śledziona J et al. (2026). Real-Life Data of Tirzepatide Use to Support Lifestyle Modification in research… [PMID: 42075085]
Laboratory literature summary: Real-Life Data of Tirzepatide Use to Support Lifestyle Modification in research subjects with Metabolic Syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Liuzzo G et al. (2026). Laboratory research record on GLP-2T [PMID: 41879154]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Kozato A et al. (2026). Evolving utilization of bariatric surgery since the rise of semaglutide and tirzepatide [PMID: 42467193]
Laboratory literature summary: Evolving utilization of bariatric surgery since the rise of semaglutide and tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
La Vignera S et al. (2026). Do Fasting GLP-1 and GIP Levels Predict the Initial Pharmacological Response to… [PMID: 42449760]
Laboratory literature summary: Do Fasting GLP-1 and GIP Levels Predict the Initial Pharmacological Response to Semaglutide and Tirzepatide?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Singh R (2025). Laboratory research record on GLP-2T [PMID: 40443633]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Hassan A (2026). Severe Euglycemic Ketoacidosis Secondary to Tirzepatide Use for body-composition research [PMID: 42147686]
Laboratory literature summary: Severe Euglycemic Ketoacidosis Secondary to Tirzepatide Use for body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Buckley AJ et al. (2025). Laboratory research record on GLP-2T [PMID: 41051410]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Chen M et al. (2026). Beyond research subjects Factors: Are we Missing the Surgical Context in Comparing… [PMID: 41801639]
Laboratory literature summary: Beyond research subjects Factors: Are we Missing the Surgical Context in Comparing Tirzepatide and Semaglutide Post-CABG?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Juszczak M et al. (2025). Investigation of metabolic research models in spinal cord injury with tirzepatide: a… [PMID: 40025019]
Laboratory literature summary: investigation of metabolic research models in spinal cord injury with tirzepatide: a case report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sathambihai T et al. (2025). Laboratory research record on GLP-2T [PMID: 41431533]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Al-Refaey SM et al. (2026). A Fluorescent Probe-Based Platform for Precise Pharmaceutical Analysis and Quality… [PMID: 41649304]
Laboratory literature summary: A Fluorescent Probe-Based Platform for Precise Pharmaceutical Analysis and Quality Assessment of Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kemmotsu R et al. (2026). Laboratory research record on GLP-2T [PMID: 41971636]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Asada K et al. (2026). A Case of Prolonged Paralytic Ileus Following a Tirzepatide Overdose in a research… [PMID: 42144326]
Laboratory literature summary: A Case of Prolonged Paralytic Ileus Following a Tirzepatide Overdose in a research subjects with Bulimia Nervosa. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Goodman W et al. (2026). Symmetrical drug-related intertriginous and flexural exanthema associated with tirzepatide [PMID: 42064416]
Laboratory literature summary: Symmetrical drug-related intertriginous and flexural exanthema associated with tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Centor RM et al. (2025). Laboratory research record on GLP-2T [PMID: 40759012]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Newcomer K et al. (2025). Benign small bowel pneumatosis intestinalis: report of a rare adverse effect of… [PMID: 41458895]
Laboratory literature summary: Benign small bowel pneumatosis intestinalis: report of a rare adverse effect of tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Luke M et al. (2026). Laboratory research record on GLP-2T [PMID: 42088720]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Polisky M et al. (2026). Insulinoma Unmasked By Tirzepatide: A Rare Case of Postprandial Hypoglycemia In a… [PMID: 41356535]
Laboratory literature summary: Insulinoma Unmasked By Tirzepatide: A Rare Case of Postprandial Hypoglycemia In a Nondiabetic research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sikorska LM et al. (2026). Laboratory research record on GLP-2T [PMID: 41788104]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Velusamy B et al. (2026). Rapid remission of Hailey-Hailey disease with tirzepatide research protocol: A case report [PMID: 42011394]
Laboratory literature summary: Rapid remission of Hailey-Hailey disease with tirzepatide research protocol: A case report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Raptis D et al. (2026). Laboratory research record on GLP-2T [PMID: 41613297]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wen J et al. (2026). Brachial Plexopathy Following Rapid body-composition research from Tirzepatide: A Case… [PMID: 42263282]
Laboratory literature summary: Brachial Plexopathy Following Rapid body-composition research from Tirzepatide: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Karnan N et al. (2025). Evaluating the observed endpoints of ChatGPT vs. Google Gemini in Generating research… [PMID: 40351930]
Laboratory literature summary: Evaluating the observed endpoints of ChatGPT vs. Google Gemini in Generating research subjects Education Materials for GLP-1 Receptor…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Burson JR et al. (2026). Lithium toxicity following a change from semaglutide to tirzepatide for… [PMID: 41646202]
Laboratory literature summary: Lithium toxicity following a change from semaglutide to tirzepatide for body-composition research management. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Beshay LH et al. (2026). Mixed Medullary and Papillary Thyroid Carcinoma in a research subjects on Tirzepatide [PMID: 42220693]
Laboratory literature summary: Mixed Medullary and Papillary Thyroid Carcinoma in a research subjects on Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Aung ET et al. (2026). Laboratory research record on GLP-2T [PMID: 41802735]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Neptune Rosa JM et al. (2026). Psoriasis flare following tirzepatide initiation in a research subjects with plaque… [PMID: 42005509]
Laboratory literature summary: Psoriasis flare following tirzepatide initiation in a research subjects with plaque psoriasis in remission: A case report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Azzam AY et al. (2026). Cardiovascular and Cerebrovascular Outcomes Risk Reduction Associated With Semaglutide… [PMID: 42489387]
Laboratory literature summary: Cardiovascular and Cerebrovascular Outcomes Risk Reduction Associated With Semaglutide vs Tirzepatide: A Target Trial Emulation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tsai KW et al. (2025). Laboratory research record on GLP-2T [PMID: 41225710]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Toraih EA et al. (2025). The Risk of Vestibular Disorders with Semaglutide and Tirzepatide: Findings from a… [PMID: 40426877]
Laboratory literature summary: The Risk of Vestibular Disorders with Semaglutide and Tirzepatide: Findings from a Large Real-World Cohort. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Krumholz HM et al. (2024). Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1… [PMID: 39084707]
Laboratory literature summary: Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Frandsen CS et al. (2023). Laboratory research record on GLP-2T [PMID: 37385274]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
le Roux CW et al. (2023). Tirzepatide for the investigation of metabolic research models: Rationale and design… [PMID: 36478180]
Laboratory literature summary: Tirzepatide for the investigation of metabolic research models: Rationale and design of the SURMOUNT laboratory development program. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Karagiannis T et al. (2026). In adults with T2D and ASCVD, tirzepatide was noninferior to dulaglutide for a… [PMID: 42081805]
Laboratory literature summary: In adults with T2D and ASCVD, tirzepatide was noninferior to dulaglutide for a composite CV outcome at a median 4 y. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Huang YN et al. (2025). Comparative ocular outcomes of tirzepatide versus other anti-metabolic research models… [PMID: 40750822]
Laboratory literature summary: Comparative ocular outcomes of tirzepatide versus other anti-metabolic research models medications in people with metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Huang M et al. (2025). A retrospective observational study on case reports of adverse drug reactions (ADRs)… [PMID: 40667509]
Laboratory literature summary: A retrospective observational study on case reports of adverse drug reactions (ADRs) to tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kamrul-Hasan ABM et al. (2024). Hepatobiliary effects and laboratory profile of tirzepatide: A systematic review and… [PMID: 39268951]
Laboratory literature summary: Hepatobiliary effects and laboratory profile of tirzepatide: A systematic review and meta-analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bao Y et al. (2024). Characterization of tirzepatide-studied research subjects achieving different glycemic… [PMID: 38803303]
Laboratory literature summary: Characterization of tirzepatide-studied research subjects achieving different glycemic control levels in SURPASS-AP-Combo. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Davidson MB (2022). Laboratory research record on GLP-2T [PMID: 36191308]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Shin MH et al. (2026). Multidimensional Predictors of Tirzepatide observed endpoints: laboratory, Genetic,… [PMID: 42198465]
Laboratory literature summary: Multidimensional Predictors of Tirzepatide observed endpoints: laboratory, Genetic, and Molecular Biomarkers for Glycemic, Weight, and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jordan B et al. (2026). Laboratory research record on GLP-2T [PMID: 42010938]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Barenbaum SR et al. (2026). Real-World body-composition research Outcomes in Weight-Reduced research subjects… [PMID: 41902614]
Laboratory literature summary: Real-World body-composition research Outcomes in Weight-Reduced research subjects studied With Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Abdul-Hafez HA et al. (2026). Tirzepatide and Cardiovascular Outcomes: A Narrative Review of Mechanisms, observed… [PMID: 41566974]
Laboratory literature summary: Tirzepatide and Cardiovascular Outcomes: A Narrative Review of Mechanisms, observed endpoints and Implications for Heart Failure Management. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Campbell LA et al. (2026). EBM BLS: Tirzepatide Leads to Resolution of Metabolic Dysfunction-Associated… [PMID: 41540304]
Laboratory literature summary: EBM BLS: Tirzepatide Leads to Resolution of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Without Worsening of Fibrosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Adamidis N et al. (2025). Laboratory research record on GLP-2T [PMID: 40662047]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
O'Keefe JH et al. (2025). Anti-consumption agents: Tirzepatide and semaglutide for investigating metabolic… [PMID: 39743126]
Laboratory literature summary: Anti-consumption agents: Tirzepatide and semaglutide for investigating metabolic research models-related diseases and addictions, and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
MacIsaac RJ et al. (2023). Laboratory research record on GLP-2T [PMID: 37824027]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Heise T et al. (2023). Laboratory research record on GLP-2T [PMID: 36857477]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
De Block C et al. (2023). Laboratory research record on GLP-2T [PMID: 35929488]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Almansour HA et al. (2025). Real-World laboratory profile Concerns of Tirzepatide: A Retrospective Analysis of… [PMID: 41008391]
Laboratory literature summary: Real-World laboratory profile Concerns of Tirzepatide: A Retrospective Analysis of FAERS Data (2022-2025). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Horn DB et al. (2025). Laboratory research record on GLP-2T [PMID: 40916045]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Rubin EJ et al. (2025). NEJM at AHA – Tirzepatide for Heart Failure with Preserved Ejection Fraction and… [PMID: 39555797]
Laboratory literature summary: NEJM at AHA – Tirzepatide for Heart Failure with Preserved Ejection Fraction and metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Taktaz F et al. (2024). Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence… [PMID: 38987789]
Laboratory literature summary: Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wong ND et al. (2025). US Population Eligibility and Estimated Impact of Tirzepatide investigation on… [PMID: 38850368]
Laboratory literature summary: US Population Eligibility and Estimated Impact of Tirzepatide investigation on metabolic research models Prevalence and Cardiovascular…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jamal M et al. (2024). Semaglutide and Tirzepatide for the Management of Weight Recurrence After Sleeve… [PMID: 38430320]
Laboratory literature summary: Semaglutide and Tirzepatide for the Management of Weight Recurrence After Sleeve Gastrectomy: A Retrospective Cohort Study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ebell MH (2023). Laboratory research record on GLP-2T [PMID: 36689986]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Saeed ZI et al. (2025). Semaglutide and Tirzepatide for the investigation of metabolic research models and… [PMID: 41410846]
Laboratory literature summary: Semaglutide and Tirzepatide for the investigation of metabolic research models and Weight-Related Comorbidities: A Narrative Review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2025). Correction to: "laboratory Consequences of Delayed Gastric Emptying With GLP-1… [PMID: 40638456]
Laboratory literature summary: Correction to: "laboratory Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide". Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bin Abdul Malik MH et al. (2025). Evaluating the Impact of Tirzepatide on laboratory Outcomes in research subjects With… [PMID: 40357081]
Laboratory literature summary: Evaluating the Impact of Tirzepatide on laboratory Outcomes in research subjects With Heart Failure. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Suzuki Y (2024). Laboratory research record on GLP-2T [PMID: 38061447]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Boye KS et al. (2026). Laboratory research record on GLP-2T [PMID: 41911554]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Mehta S et al. (2026). Dual GIPR and GLP-1R Agonist Tirzepatide Is Associated With Fewer Asthma Exacerbations… [PMID: 41708478]
Laboratory literature summary: Dual GIPR and GLP-1R Agonist Tirzepatide Is Associated With Fewer Asthma Exacerbations in Adults With metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fiorucci S et al. (2025). Tirzepatide for metabolic dysfunction-associated steatohepatitis: results from phase… [PMID: 40782123]
Laboratory literature summary: Tirzepatide for metabolic dysfunction-associated steatohepatitis: results from phase II laboratory trials and perspectives. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhao L et al. (2025). Association of tirzepatide with cardiometabolic benefits in Chinese adults: post hoc… [PMID: 40437798]
Laboratory literature summary: Association of tirzepatide with cardiometabolic benefits in Chinese adults: post hoc subgroup analysis of SURMOUNT-CN study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ma J et al. (2025). Laboratory research record on GLP-2T [PMID: 39212900]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Cariou B et al. (2024). Laboratory research record on GLP-2T [PMID: 38528819]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Galindo RJ et al. (2026). Laboratory research record on GLP-2T [PMID: 41885866]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Monzo L et al. (2026). Semaglutide vs tirzepatide in research subjects with metabolic research models and… [PMID: 41711744]
Laboratory literature summary: Semaglutide vs tirzepatide in research subjects with metabolic research models and HFpEF: a report from a global federated research network. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bonga KN et al. (2026). Laboratory research record on GLP-2T [PMID: 41605830]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Van Bruggen FH (2026). Re "Tirzepatide for sleep-disordered breathing in SURMOUNT-OSA" – Perspective on… [PMID: 41260002]
Laboratory literature summary: Re "Tirzepatide for sleep-disordered breathing in SURMOUNT-OSA" – Perspective on potential weight-independent effects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kumar AJ et al. (2025). What impact could tirzepatide have on major cardiovascular complications in research… [PMID: 40946170]
Laboratory literature summary: What impact could tirzepatide have on major cardiovascular complications in research subjects with obstructive sleep apnea?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sun Y et al. (2026). Tirzepatide reduces intracellular lipid content by promoting the browning of white fat… [PMID: 41506434]
Laboratory literature summary: Tirzepatide reduces intracellular lipid content by promoting the browning of white fat via the cAMP signaling pathway. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Richards R et al. (2025). Laboratory research record on GLP-2T [PMID: 40838489]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Hoog MM et al. (2025). Laboratory research record on GLP-2T [PMID: 40512029]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Mather KJ et al. (2025). Greater improvement in insulin sensitivity per unit body-composition research… [PMID: 39762971]
Laboratory literature summary: Greater improvement in insulin sensitivity per unit body-composition research associated with tirzepatide versus semaglutide: An…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gibble TH et al. (2026). Laboratory research record on GLP-2T [PMID: 42436850]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Ticho AL et al. (2026). A Subphenotype of metabolic research models With Reduced Enteroendocrine Glucagon-Like… [PMID: 42250890]
Laboratory literature summary: A Subphenotype of metabolic research models With Reduced Enteroendocrine Glucagon-Like Peptide 1 Synthesis and Enhanced Tirzepatide Response. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sekhon S et al. (2026). Ischemic Colitis Associated With Tirzepatide research protocol in a Young research… [PMID: 41694961]
Laboratory literature summary: Ischemic Colitis Associated With Tirzepatide research protocol in a Young research models research subjects: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Krüger N et al. (2025). Semaglutide and Tirzepatide in research subjects With Heart Failure With Preserved… [PMID: 40886075]
Laboratory literature summary: Semaglutide and Tirzepatide in research subjects With Heart Failure With Preserved Ejection Fraction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pedicino D et al. (2025). Laboratory research record on GLP-2T [PMID: 40249363]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Zhao F et al. (2022). Structural insights into multiplexed pharmacological actions of tirzepatide and… [PMID: 35217653]
Laboratory literature summary: Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Harbi MH et al. (2026). Tirzepatide vs. semaglutide for metabolic research models, glycemic control, and… [PMID: 42100257]
Laboratory literature summary: Tirzepatide vs. semaglutide for metabolic research models, glycemic control, and cardiovascular outcomes: a narrative review of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shah I et al. (2025). Tirzepatide-Induced Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)… [PMID: 41179268]
Laboratory literature summary: Tirzepatide-Induced Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Presenting With Seizures. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tan MC et al. (2026). Exploring the cardiopulmonary effects of tirzepatide in atrial fibrillation and… [PMID: 40998187]
Laboratory literature summary: Exploring the cardiopulmonary effects of tirzepatide in atrial fibrillation and comorbid chronic obstructive pulmonary disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kammaripalle TKC et al. (2025). Life-Threatening Ventricular Fibrillation Linked to High-exposure level… [PMID: 40621252]
Laboratory literature summary: Life-Threatening Ventricular Fibrillation Linked to High-exposure level Tirzepatide-Induced Gastrointestinal observed outcomes in study models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yang Y et al. (2025). Laboratory research record on GLP-2T [PMID: 38965127]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Chen L et al. (2024). Tirzepatide protects against doxorubicin-induced cardiotoxicity by inhibiting… [PMID: 38801993]
Laboratory literature summary: Tirzepatide protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and inflammation via PI3K/Akt signaling. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Avgerinos I et al. (2024). Laboratory research record on GLP-2T [PMID: 38654653]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Frias JP et al. (2024). Tirzepatide Improved Markers of Islet Cell Function and Insulin Sensitivity in People… [PMID: 38252888]
Laboratory literature summary: Tirzepatide Improved Markers of Islet Cell Function and Insulin Sensitivity in People With T2D (SURPASS-2). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chavda VP et al. (2022). Laboratory research record on GLP-2T [PMID: 35807558]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Sun X et al. (2025). Tirzepatide Synergizes with Leptin on body-composition research and Restoring… [PMID: 41509321]
Laboratory literature summary: Tirzepatide Synergizes with Leptin on body-composition research and Restoring Metabolic Homeostasis in Diet-induced metabolic research…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gourgari E et al. (2025). Early-Onset metabolic research models and Tirzepatide investigation: A Post Hoc… [PMID: 40717199]
Laboratory literature summary: Early-Onset metabolic research models and Tirzepatide investigation: A Post Hoc Analysis of the SURMOUNT laboratory Trials. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Desai A et al. (2026). Observed endpoints of tirzepatide for body-composition research and it's comparative… [PMID: 40682732]
Laboratory literature summary: observed endpoints of tirzepatide for body-composition research and it's comparative effectiveness to body-composition research surgery…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kamrul-Hasan ABM et al. (2025). Laboratory research record on GLP-2T [PMID: 40236848]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Daou C et al. (2025). Very-low-calorie-diet, tirzepatide, and bariatric surgery: a multidisciplinary success… [PMID: 40161879]
Laboratory literature summary: Very-low-calorie-diet, tirzepatide, and bariatric surgery: a multidisciplinary success in super-super metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Niu S et al. (2024). Laboratory research record on GLP-2T [PMID: 37867175]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Gibble TH et al. (2026). Laboratory research record on GLP-2T [PMID: 42518363]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Lebwohl M et al. (2026). Laboratory research record on GLP-2T [PMID: 42139049]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Eisa N et al. (2026). Laboratory research record on GLP-2T [PMID: 42061648]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Galindo RJ et al. (2026). Reversion to normoglycemia with tirzepatide vs semaglutide in participants with… [PMID: 42002673]
Laboratory literature summary: Reversion to normoglycemia with tirzepatide vs semaglutide in participants with metabolic research models and prediabetes: a post hoc…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kang M et al. (2026). Tirzepatide mitigates atherosclerosis progression and modulates oxLDL-mediated… [PMID: 41904760]
Laboratory literature summary: Tirzepatide mitigates atherosclerosis progression and modulates oxLDL-mediated proatherogenic effects in macrophages: evidence for M1/M2…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mazzeo A et al. (2026). Probable tirzepatide-associated limbic encephalitis with status epilepticus in a… [PMID: 41882230]
Laboratory literature summary: Probable tirzepatide-associated limbic encephalitis with status epilepticus in a research subjects with extreme metabolic research…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gopalakrishnan PP et al. (2026). Laboratory research record on GLP-2T [PMID: 41636221]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Fadini GP (2025). Laboratory research record on GLP-2T [PMID: 40526203]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Sawamura T et al. (2024). Effects of the switch from dulaglutide to tirzepatide on glycemic control, body… [PMID: 39610482]
Laboratory literature summary: Effects of the switch from dulaglutide to tirzepatide on glycemic control, body weight, and fatty liver: a retrospective study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Patoulias D et al. (2024). Laboratory research record on GLP-2T [PMID: 39018899]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Mendoza F et al. (2023). Laboratory research record on GLP-2T [PMID: 37604405]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Patoulias D et al. (2023). Tirzepatide and glucagon-like peptide-1 receptor agonists: laboratory profile always… [PMID: 37584280]
Laboratory literature summary: Tirzepatide and glucagon-like peptide-1 receptor agonists: laboratory profile always comes first!. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Batiha GE et al. (2023). Laboratory research record on GLP-2T [PMID: 37208555]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Di Napoli M et al. (2026). Sleeve gastrectomy versus tirzepatide to improve survival among research subjects with… [PMID: 42173727]
Laboratory literature summary: Sleeve gastrectomy versus tirzepatide to improve survival among research subjects with stage 5 CKD: A Markov decision analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Provenzani A et al. (2026). Laboratory profile and observed endpoints of tirzepatide in transplant recipients: a… [PMID: 41908834]
Laboratory literature summary: laboratory profile and observed endpoints of tirzepatide in transplant recipients: a systematic review and meta-analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tazhibi M et al. (2026). Resolution of severe lumbar spinal epidural lipomatosis following tirzepatide-induced… [PMID: 41587457]
Laboratory literature summary: Resolution of severe lumbar spinal epidural lipomatosis following tirzepatide-induced body-composition research: illustrative case. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shah J et al. (2026). Laboratory research record on GLP-2T [PMID: 41577258]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wilson L et al. (2026). Laboratory research record on GLP-2T [PMID: 41491349]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Fadhil NM et al. (2025). Tirzepatide alters oncogenic signaling pathways in colorectal oncology research models… [PMID: 41351362]
Laboratory literature summary: Tirzepatide alters oncogenic signaling pathways in colorectal oncology research models cells in vitro. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lesser LI et al. (2025). Laboratory research record on GLP-2T [PMID: 41183340]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Masson W et al. (2026). Anti-inflammatory effects of tirzepatide: a systematic review and meta-analysis [PMID: 41032183]
Laboratory literature summary: Anti-inflammatory effects of tirzepatide: a systematic review and meta-analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Alolayan SA et al. (2025). Ineffectiveness of tirzepatide in mitigating Doxorubicin-induced oxidative stress and… [PMID: 40894223]
Laboratory literature summary: Ineffectiveness of tirzepatide in mitigating Doxorubicin-induced oxidative stress and cognitive deficits in a rat model. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hong I et al. (2025). Effects of Tirzepatide on Low-Density Lipoprotein Cholesterol Levels in Adults: A… [PMID: 40842811]
Laboratory literature summary: Effects of Tirzepatide on Low-Density Lipoprotein Cholesterol Levels in Adults: A Systematic Review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ghosal S et al. (2026). Predicted cardiovascular risk reduction with tirzepatide vs. semaglutide:… [PMID: 42131512]
Laboratory literature summary: Predicted cardiovascular risk reduction with tirzepatide vs. semaglutide: interpretative considerations from the SURMOUNT-5 post hoc…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Brooks S et al. (2025). Acute Mesenteric Ischemia as a Severe Complication Associated With Tirzepatide: A Case… [PMID: 41416326]
Laboratory literature summary: Acute Mesenteric Ischemia as a Severe Complication Associated With Tirzepatide: A Case Report and laboratory profile Alert. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Banji D et al. (2025). Laboratory research record on GLP-2T [PMID: 41405657]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Pack A et al. (2025). What will the impact be of use of tirzepatide in research subjects with obstructive… [PMID: 40184186]
Laboratory literature summary: What will the impact be of use of tirzepatide in research subjects with obstructive sleep apnea (OSA)?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mortada I et al. (2026). Laboratory research record on GLP-2T [PMID: 42420805]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wang CY (2026). Laboratory research record on GLP-2T [PMID: 41749445]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Borner T et al. (2025). Hypophagia and body body-composition research by tirzepatide are accompanied by fewer… [PMID: 40532005]
Laboratory literature summary: Hypophagia and body body-composition research by tirzepatide are accompanied by fewer GI adverse events compared to semaglutide in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pacini G et al. (2024). The dual incretin co-agonist tirzepatide increases both insulin secretion and glucose… [PMID: 37984684]
Laboratory literature summary: The dual incretin co-agonist tirzepatide increases both insulin secretion and glucose effectiveness in model experiments in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Polyzos SA et al. (2023). Laboratory research record on GLP-2T [PMID: 36617715]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Lee YC et al. (2023). Laboratory research record on GLP-2T [PMID: 36575627]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Singh M (2022). Laboratory research record on GLP-2T [PMID: 35226523]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Rantanen R et al. (2026). Tirzepatide-Induced body-composition research and Exacerbation of Bipolar Disorder… [PMID: 42495981]
Laboratory literature summary: Tirzepatide-Induced body-composition research and Exacerbation of Bipolar Disorder With Clozapine investigation: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Im S et al. (2026). Overcoming Gastric Barriers for Oral Peptide Delivery: QbD-Based Development of Sodium… [PMID: 42514904]
Laboratory literature summary: Overcoming Gastric Barriers for Oral Peptide Delivery: QbD-Based Development of Sodium Caprate-Enabled Tirzepatide Tablets. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Edvardsson CE et al. (2026). Tirzepatide attenuates mesolimbic cocaine-evoked dopamine levels and reduces cocaine… [PMID: 41875498]
Laboratory literature summary: Tirzepatide attenuates mesolimbic cocaine-evoked dopamine levels and reduces cocaine taking, motivation and seeking behaviours in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Paternò V et al. (2025). Mediterranean diet adherence and tirzepatide: real-world evidence on adiposity indices… [PMID: 41613958]
Laboratory literature summary: Mediterranean diet adherence and tirzepatide: real-world evidence on adiposity indices and insulin resistance beyond body-composition…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Deng Z et al. (2026). Effect of Weight-Neutral investigation With Semaglutide or Tirzepatide on β-Cell… [PMID: 41354136]
Laboratory literature summary: Effect of Weight-Neutral investigation With Semaglutide or Tirzepatide on β-Cell Identity in db/db Mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Oe Y et al. (2025). Case Report: Amelioration of severe metabolic dysfunction-associated steatohepatitis… [PMID: 40491599]
Laboratory literature summary: Case Report: Amelioration of severe metabolic dysfunction-associated steatohepatitis after switching from conventional GLP-1RAs to…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Klein JA et al. (2024). Dramatic Changes in Thiopurine Metabolite Levels in a research subjects With… [PMID: 39507506]
Laboratory literature summary: Dramatic Changes in Thiopurine Metabolite Levels in a research subjects With Inflammatory Bowel Disease studied With Tirzepatide for…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fuest S et al. (2024). Laboratory research record on GLP-2T [PMID: 39090425]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Sardar MB et al. (2024). Laboratory research record on GLP-2T [PMID: 38417475]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Vinciguerra F et al. (2026). Tirzepatide for Recurrent Weight Gain after Bariatric Procedures: Real-World Evidence… [PMID: 42247124]
Laboratory literature summary: Tirzepatide for Recurrent Weight Gain after Bariatric Procedures: Real-World Evidence of observed endpoints and laboratory profile. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Provenzani A et al. (2026). Correction: laboratory profile and observed endpoints of tirzepatide in transplant… [PMID: 42137317]
Laboratory literature summary: Correction: laboratory profile and observed endpoints of tirzepatide in transplant recipients: a systematic review and meta-analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Marin RC et al. (2026). Disproportionality Analysis of Tirzepatide vs. Semaglutide and Liraglutide: System… [PMID: 41977175]
Laboratory literature summary: Disproportionality Analysis of Tirzepatide vs. Semaglutide and Liraglutide: System Organ Class-Level Post-Marketing Reporting Patterns…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ishigaki Y et al. (2026). Observed endpoints and laboratory profile of Tirzepatide in Japanese Participants With… [PMID: 41612966]
Laboratory literature summary: observed endpoints and laboratory profile of Tirzepatide in Japanese Participants With metabolic research models: A Subpopulation…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Krüger N et al. (2026). Laboratory research record on GLP-2T [PMID: 41207920]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Sonavane K et al. (2025). Acute Deep Vein Thrombosis in the Setting of Tirzepatide Use: A Case Highlighting… [PMID: 41179274]
Laboratory literature summary: Acute Deep Vein Thrombosis in the Setting of Tirzepatide Use: A Case Highlighting Emerging Concerns. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Burr E et al. (2025). The use of tirzepatide to successfully treat persistent genital arousal… [PMID: 41001580]
Laboratory literature summary: The use of tirzepatide to successfully treat persistent genital arousal disorder/genitopelvic dysesthesia: a case report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Karimi MA et al. (2025). Comparative effectiveness of semaglutide versus liraglutide, dulaglutide or… [PMID: 40444045]
Laboratory literature summary: Comparative effectiveness of semaglutide versus liraglutide, dulaglutide or tirzepatide: a systematic review and meta-analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kanbay M et al. (2023). Laboratory research record on GLP-2T [PMID: 37700437]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Mori Y et al. (2026). Laboratory research record on GLP-2T [PMID: 42512027]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wu JY et al. (2026). Comparative effectiveness of tirzepatide versus thiazolidinedione in adults with… [PMID: 42222172]
Laboratory literature summary: Comparative effectiveness of tirzepatide versus thiazolidinedione in adults with MASLD: a propensity score-matched cohort study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Attia MSM et al. (2026). Tirzepatide attenuates neurotoxicity by suppressing inflammation, apoptosis and… [PMID: 42154338]
Laboratory literature summary: Tirzepatide attenuates neurotoxicity by suppressing inflammation, apoptosis and restoring neurotrophin expression in an…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2026). Correction to: "Tirzepatide-Induced Syndrome of Inappropriate Antidiuretic Hormone… [PMID: 41613300]
Laboratory literature summary: Correction to: "Tirzepatide-Induced Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Presenting With Seizures". Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fauchier L et al. (2025). Tirzepatide in metabolic research models-Related Heart Failure With Preserved EF:… [PMID: 40562517]
Laboratory literature summary: Tirzepatide in metabolic research models-Related Heart Failure With Preserved EF: body-composition research and Structural Adaptations. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Look M et al. (2025). Laboratory research record on GLP-2T [PMID: 39996356]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Stoll F et al. (2025). Tackling suboptimal laboratory response after metabolic bariatric surgery: Impact of… [PMID: 39952885]
Laboratory literature summary: Tackling suboptimal laboratory response after metabolic bariatric surgery: Impact of tirzepatide on body-composition research and body…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fujihara K et al. (2024). Achieving normoglycaemia with tirzepatide: Post hoc exploratory analysis of the… [PMID: 39192522]
Laboratory literature summary: Achieving normoglycaemia with tirzepatide: Post hoc exploratory analysis of the SURPASS J-mono and J-combo studies. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Urva S et al. (2024). Model-based simulation of glycaemic effect and body body-composition research when… [PMID: 38407177]
Laboratory literature summary: Model-based simulation of glycaemic effect and body body-composition research when switching from semaglutide or dulaglutide to once…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Meng Z et al. (2023). A systematic review of the laboratory profile of tirzepatide-a new dual GLP1 and GIP… [PMID: 37051199]
Laboratory literature summary: A systematic review of the laboratory profile of tirzepatide-a new dual GLP1 and GIP agonist – is its laboratory profile profile acceptable?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Guo X et al. (2026). Laboratory profile Profile of Tirzepatide in Real-World laboratory Practice: A… [PMID: 42443144]
Laboratory literature summary: laboratory profile Profile of Tirzepatide in Real-World laboratory Practice: A Pharmacovigilance Study Using the FAERS Database. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Abdelshafey EE et al. (2026). Laboratory research record on GLP-2T [PMID: 42381258]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Almansour AH (2025). Acute Kidney Injury After Accelerated exposure design of Tirzepatide in a research… [PMID: 41351866]
Laboratory literature summary: Acute Kidney Injury After Accelerated exposure design of Tirzepatide in a research subjects with Multiple Comorbidities: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Störk S et al. (2025). [Tirzepatide for heart failure with preserved ejection fraction (HFpEF) and metabolic… [PMID: 40640401]
Laboratory literature summary: [Tirzepatide for heart failure with preserved ejection fraction (HFpEF) and metabolic research models-the cardiometabolic turnaround?]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pearson ER et al. (2025). Predictors of Initial and Sustained Glycemic and Weight Response to Tirzepatide: A… [PMID: 40633089]
Laboratory literature summary: Predictors of Initial and Sustained Glycemic and Weight Response to Tirzepatide: A Post Hoc Analysis of SURPASS-4. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lam CSP et al. (2025). Tirzepatide for reduction of morbidity and mortality in adults with metabolic research… [PMID: 40545827]
Laboratory literature summary: Tirzepatide for reduction of morbidity and mortality in adults with metabolic research models: rationale and design of the SURMOUNT-MMO…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kong W et al. (2024). Tirzepatide as an innovative investigation strategy in a pre-laboratory model of… [PMID: 39388742]
Laboratory literature summary: Tirzepatide as an innovative investigation strategy in a pre-laboratory model of metabolic research models-driven endometrial oncology…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gasbjerg LS et al. (2023). The importance of glucose-dependent insulinotropic polypeptide receptor activation for… [PMID: 37551549]
Laboratory literature summary: The importance of glucose-dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shimada T et al. (2026). Tirzepatide-Induced Functional Small Bowel Obstruction in a Surgically Naïve research… [PMID: 42404678]
Laboratory literature summary: Tirzepatide-Induced Functional Small Bowel Obstruction in a Surgically Naïve research subjects: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wadden TA et al. (2026). Psychiatric laboratory profile of Tirzepatide in People With metabolic research models… [PMID: 41537305]
Laboratory literature summary: Psychiatric laboratory profile of Tirzepatide in People With metabolic research models and No Known Major Psychopathology: A Post Hoc…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Reis-Barbosa PH et al. (2025). Laboratory research record on GLP-2T [PMID: 41191986]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Borlaug BA et al. (2025). Impact of Body Mass Index, Central Adiposity, and body-composition research on the… [PMID: 40701669]
Laboratory literature summary: Impact of Body Mass Index, Central Adiposity, and body-composition research on the Benefits of Tirzepatide in HFpEF: The SUMMIT Trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cheskin LJ et al. (2024). In adults with moderate-to-severe OSA and metabolic research models, tirzepatide… [PMID: 39348697]
Laboratory literature summary: In adults with moderate-to-severe OSA and metabolic research models, tirzepatide reduced apnea-hypopnea events vs. control arm. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ma Z et al. (2023). Laboratory research record on GLP-2T [PMID: 37096236]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Matza LS et al. (2022). Laboratory research record on GLP-2T [PMID: 35513765]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Nadolsky S et al. (2026). Laboratory research record on GLP-2T [PMID: 42518361]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Mestres-Arenas A et al. (2026). Differential effects of the anti-metabolic research models drug tirzepatide on adipose… [PMID: 41592522]
Laboratory literature summary: Differential effects of the anti-metabolic research models drug tirzepatide on adipose tissues: Brown fat as a key target. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Malhotra A et al. (2026). Laboratory research record on GLP-2T [PMID: 41540105]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wu JY et al. (2026). Tirzepatide versus SGLT2 inhibitors for MASLD: a multi-institutional propensity… [PMID: 41535629]
Laboratory literature summary: Tirzepatide versus SGLT2 inhibitors for MASLD: a multi-institutional propensity score-matched cohort study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gandhi A et al. (2025). Comparative Renal laboratory profile of Tirzepatide and Semaglutide: An FDA Adverse… [PMID: 41227073]
Laboratory literature summary: Comparative Renal laboratory profile of Tirzepatide and Semaglutide: An FDA Adverse Event Reporting System (FAERS)-Disproportionality Study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fauchier L et al. (2025). Cardiovascular outcomes with tirzepatide in heart failure with preserved ejection… [PMID: 40880118]
Laboratory literature summary: Cardiovascular outcomes with tirzepatide in heart failure with preserved ejection fraction associated with metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhang Z et al. (2025). Laboratory research record on GLP-2T [PMID: 40631601]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Popovic DS et al. (2024). Laboratory research record on GLP-2T [PMID: 38889536]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Buckley A et al. (2024). Laboratory research record on GLP-2T [PMID: 38783825]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Al-Sabah S et al. (2024). Effect of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide… [PMID: 39047721]
Laboratory literature summary: Effect of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist (Tirzepatide) versus Bariatric…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Alfaris N et al. (2026). Tirzepatide for metabolic research models in Adults ≥ 65 Years: A Post Hoc Analysis of… [PMID: 42303274]
Laboratory literature summary: Tirzepatide for metabolic research models in Adults ≥ 65 Years: A Post Hoc Analysis of the SURMOUNT and SUMMIT laboratory Trials. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sawamura T et al. (2026). Laboratory research record on GLP-2T [PMID: 41850834]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Cunningham JM et al. (2026). Laboratory research record on GLP-2T [PMID: 41269512]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Fahim SA et al. (2025). Comparative laboratory profile and observed outcomes in study models of semaglutide and tirzepatide:… [PMID: 41177120]
Laboratory literature summary: Comparative laboratory profile and observed outcomes in study models of semaglutide and tirzepatide: Implications for laboratory decision-making in metabolic…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bittencourt JOA et al. (2026). Laboratory research record on GLP-2T [PMID: 41412277]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Viana DPDC et al. (2025). Tirzepatide as a Potential Disease-Modifying research protocol in Lipedema: A… [PMID: 41226777]
Laboratory literature summary: Tirzepatide as a Potential Disease-Modifying research protocol in Lipedema: A Narrative Review on Bridging Metabolism, Inflammation, and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wu JY et al. (2025). Response to comments on tirzepatide versus bariatric metabolic surgery in adults with… [PMID: 40914231]
Laboratory literature summary: Response to comments on tirzepatide versus bariatric metabolic surgery in adults with obstructive sleep apnea and metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Capehorn M et al. (2025). Laboratory research record on GLP-2T [PMID: 40788459]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Babirak SP (2023). Laboratory research record on GLP-2T [PMID: 37520761]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Choi H et al. (2026). Laboratory research record on GLP-2T [PMID: 42209262]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Chunduri S et al. (2026). Laboratory research record on GLP-2T [PMID: 40938549]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Vilsbøll T et al. (2025). Laboratory research record on GLP-2T [PMID: 40746012]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Hartman ML et al. (2025). Consistent improvements in liver histology across subgroups in a post hoc analysis of… [PMID: 40689147]
Laboratory literature summary: Consistent improvements in liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gibble TH et al. (2025). Laboratory research record on GLP-2T [PMID: 40480878]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Evans M et al. (2025). Laboratory research record on GLP-2T [PMID: 40251452]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Tchang BG et al. (2025). Laboratory research record on GLP-2T [PMID: 40074721]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Chuang MH et al. (2024). Laboratory research record on GLP-2T [PMID: 39133485]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Otsuka E et al. (2024). Laboratory research record on GLP-2T [PMID: 38873429]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Rosenstock J et al. (2023). Laboratory research record on GLP-2T [PMID: 37786396]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Scheen AJ et al. (2022). Laboratory research record on GLP-2T [PMID: 36004653]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Omura T et al. (2026). Outpatient Dispensing Patterns and Changes in Tirzepatide Strength Mix in Japan: A… [PMID: 42535213]
Laboratory literature summary: Outpatient Dispensing Patterns and Changes in Tirzepatide Strength Mix in Japan: A Study Using the National Open Claims Data. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Adams EW et al. (2026). Thyroid Dysfunction Following Tirzepatide Use in a Post-thyroidectomy research… [PMID: 42109981]
Laboratory literature summary: Thyroid Dysfunction Following Tirzepatide Use in a Post-thyroidectomy research subjects on Stable Levothyroxine research protocol: A…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kramer CM et al. (2025). Reply: Tirzepatide in metabolic research models-Related Heart Failure With Preserved… [PMID: 40562518]
Laboratory literature summary: Reply: Tirzepatide in metabolic research models-Related Heart Failure With Preserved EF: body-composition research and Structural…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mody R et al. (2025). Laboratory research record on GLP-2T [PMID: 39794609]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Hu S et al. (2024). Laboratory research record on GLP-2T [PMID: 38738340]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Vázquez LA et al. (2024). Laboratory research record on GLP-2T [PMID: 38722495]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Vear A et al. (2026). Preventative semaglutide and tirzepatide investigation does not alter disease… [PMID: 42413499]
Laboratory literature summary: Preventative semaglutide and tirzepatide investigation does not alter disease progression in the 5xFAD mouse model of neurodegeneration…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gisondi P et al. (2026). Effects of Tirzepatide on Metabolic Parameters in research subjects with Psoriasis and… [PMID: 42240733]
Laboratory literature summary: Effects of Tirzepatide on Metabolic Parameters in research subjects with Psoriasis and metabolic research models: 24-Week Real-World Study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Seminara G et al. (2026). Laboratory research record on GLP-2T [PMID: 41801155]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Hiraide T et al. (2025). Laboratory research record on GLP-2T [PMID: 41462404]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Fukaishi T et al. (2025). Laboratory research record on GLP-2T [PMID: 40786468]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wang M et al. (2025). Depression and suicide/self-injury signals for body-composition research medications:… [PMID: 40523410]
Laboratory literature summary: Depression and suicide/self-injury signals for body-composition research medications: A disproportionality analysis of semaglutide,…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Peters AL et al. (2025). Improved HbA1c and Body Weight in GADA-Positive Individuals studied With Tirzepatide:… [PMID: 38824910]
Laboratory literature summary: Improved HbA1c and Body Weight in GADA-Positive Individuals studied With Tirzepatide: A Post Hoc Analysis of SURPASS. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mather KJ et al. (2024). Effects of Tirzepatide vs Semaglutide on β-Cell Function, Insulin Sensitivity, and… [PMID: 38795393]
Laboratory literature summary: Effects of Tirzepatide vs Semaglutide on β-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tanyous AI et al. (2026). Weight Drop-Foot Drop: A Case Series of Peroneal Nerve Palsy from Leg Crossing after… [PMID: 42524366]
Laboratory literature summary: Weight Drop-Foot Drop: A Case Series of Peroneal Nerve Palsy from Leg Crossing after Tirzepatide-Mediated body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Demircan F et al. (2026). Effect of short-term tirzepatide investigation on mean platelet volume in research… [PMID: 42464179]
Laboratory literature summary: Effect of short-term tirzepatide investigation on mean platelet volume in research subjects with metabolic research models: a…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Polsky S et al. (2026). Laboratory research record on GLP-2T [PMID: 42452840]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Ciudin A et al. (2026). Laboratory research record on GLP-2T [PMID: 42050884]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Hussain SM et al. (2026). Tolerability and Effectiveness of Tirzepatide in Kidney Transplant Recipients:… [PMID: 41952049]
Laboratory literature summary: Tolerability and Effectiveness of Tirzepatide in Kidney Transplant Recipients: Real-world Experience From a Single-center Study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Barrea L et al. (2026). Real-world data of tirzepatide in metabolic research models management: a multicenter… [PMID: 41768862]
Laboratory literature summary: Real-world data of tirzepatide in metabolic research models management: a multicenter study by the Italian Society of metabolic research…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Albokhadaim I (2026). Laboratory research record on GLP-2T [PMID: 41756101]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Liu S (2026). Laboratory research record on GLP-2T [PMID: 41240220]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Taha MME et al. (2026). Laboratory research record on GLP-2T [PMID: 40900331]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Alhowail A et al. (2025). Laboratory research record on GLP-2T [PMID: 40771859]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Meira E Cruz M (2025). Body-composition research, wakefulness, and what's missing: addressing comorbid… [PMID: 40637266]
Laboratory literature summary: body-composition research, wakefulness, and what's missing: addressing comorbid insomnia and sleep apnea in the era of tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kramer CM et al. (2025). Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in metabolic research… [PMID: 39566869]
Laboratory literature summary: Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in metabolic research models-Related Heart Failure: SUMMIT CMR Substudy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zile MR et al. (2025). Effects of Tirzepatide on the laboratory Trajectory of research subjects With Heart… [PMID: 39556714]
Laboratory literature summary: Effects of Tirzepatide on the laboratory Trajectory of research subjects With Heart Failure, Preserved Ejection Fraction, and metabolic…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Feng P et al. (2023). Laboratory research record on GLP-2T [PMID: 37285081]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Razzaki TS et al. (2022). Laboratory research record on GLP-2T [PMID: 36199834]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Yu Y et al. (2022). Laboratory research record on GLP-2T [PMID: 36119737]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Urva S et al. (2022). Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1… [PMID: 35674880]
Laboratory literature summary: Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gu S (2026). Adverse Events Associated with Tirzepatide: Updated Pharmacovigilance Analysis Using… [PMID: 41531800]
Laboratory literature summary: Adverse Events Associated with Tirzepatide: Updated Pharmacovigilance Analysis Using FAERS (2022 Q1-2025 Q1) with an Adapted…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hossain A et al. (2025). Laboratory research record on GLP-2T [PMID: 41409973]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Aronne LJ et al. (2024). Laboratory research record on GLP-2T [PMID: 38078870]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Tanaka Y et al. (2026). Case Report: Dramatic metabolic improvement with tirzepatide in a research subjects… [PMID: 42422421]
Laboratory literature summary: Case Report: Dramatic metabolic improvement with tirzepatide in a research subjects with acquired partial lipodystrophy following…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jalan A et al. (2026). A Convergent Hybrid Gram-Scale Synthesis of Tirzepatide: Tangential Flow Filtration… [PMID: 41437654]
Laboratory literature summary: A Convergent Hybrid Gram-Scale Synthesis of Tirzepatide: Tangential Flow Filtration Assisted Native Chemical Ligation-Desulfurization…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sharafeldin M et al. (2025). Severe Adverse Effects of Tirzepatide Overdose Requiring Intensive Care Unit Admission… [PMID: 41368024]
Laboratory literature summary: Severe Adverse Effects of Tirzepatide Overdose Requiring Intensive Care Unit Admission and Complex Rehabilitation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hoog MM et al. (2025). Laboratory research record on GLP-2T [PMID: 41066072]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Sathiavageesan S et al. (2026). Laboratory research record on GLP-2T [PMID: 40966606]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wang J et al. (2025). Tirzepatide Induces Ferroptosis in Glioblastoma Cell Lines via the SOX2/SLC7A11 Axis:… [PMID: 40678831]
Laboratory literature summary: Tirzepatide Induces Ferroptosis in Glioblastoma Cell Lines via the SOX2/SLC7A11 Axis: A Potential investigational Strategy for Glioma…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ferch M et al. (2025). Effectiveness of the Dual GIP/GLP1-Agonist Tirzepatide in 2 Cases of Alström Syndrome,… [PMID: 40302276]
Laboratory literature summary: Effectiveness of the Dual GIP/GLP1-Agonist Tirzepatide in 2 Cases of Alström Syndrome, a Rare metabolic research models Syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sillassen CDB et al. (2025). Adverse effects with tirzepatide: a protocol for a systematic review with… [PMID: 40233950]
Laboratory literature summary: Adverse effects with tirzepatide: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hunter Gibble T et al. (2025). Laboratory research record on GLP-2T [PMID: 40084533]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Forte V et al. (2025). Laboratory research record on GLP-2T [PMID: 39840872]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Garg SK et al. (2024). Laboratory research record on GLP-2T [PMID: 38512447]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Urva S et al. (2021). Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor… [PMID: 33778934]
Laboratory literature summary: Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Spiazzi BF et al. (2026). Laboratory research record on GLP-2T [PMID: 42442557]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Sattar N et al. (2026). Shifts in waist-to-height ratio categories within tirzepatide groups: a post-hoc… [PMID: 42082865]
Laboratory literature summary: Shifts in waist-to-height ratio categories within tirzepatide groups: a post-hoc analysis of SURMOUNT-1. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jansson AK et al. (2026). Laboratory research record on GLP-2T [PMID: 41491340]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Gad HY et al. (2025). Laboratory research record on GLP-2T [PMID: 41438327]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Glembotski CC (2025). Tirzepatide protects the heart from doxorubicin-induced cardiotoxicity by modulating… [PMID: 41077767]
Laboratory literature summary: Tirzepatide protects the heart from doxorubicin-induced cardiotoxicity by modulating endoplasmic reticulum (ER) stress and HMGCoA…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Neubauer Z et al. (2025). Increased risk of telogen effluvium with tirzepatide compared to other… [PMID: 40848975]
Laboratory literature summary: Increased risk of telogen effluvium with tirzepatide compared to other body-composition research medications: A retrospective cohort…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Trinh H et al. (2025). Laboratory research record on GLP-2T [PMID: 40116184]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Liu Q et al. (2023). Tirzepatide attenuates lipopolysaccharide-induced left ventricular remodeling and… [PMID: 37196559]
Laboratory literature summary: Tirzepatide attenuates lipopolysaccharide-induced left ventricular remodeling and dysfunction by inhibiting the TLR4/NF-kB/NLRP3 pathway. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rutter MK et al. (2026). Laboratory research record on GLP-2T [PMID: 42297568]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Akturk HK et al. (2026). Laboratory research record on GLP-2T [PMID: 41804758]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Martin CK et al. (2025). Laboratory research record on GLP-2T [PMID: 40555748]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Safwan M et al. (2025). Laboratory research record on GLP-2T [PMID: 40189856]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Kamrul-Hasan ABM et al. (2025). Laboratory research record on GLP-2T [PMID: 39814031]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Gudzune KA et al. (2025). Laboratory research record on GLP-2T [PMID: 39497468]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Mather KJ et al. (2024). Laboratory research record on GLP-2T [PMID: 37989596]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Heerspink HJL et al. (2023). Effects of Tirzepatide Versus Insulin Glargine on Cystatin C-Based Kidney Function: A… [PMID: 37267479]
Laboratory literature summary: Effects of Tirzepatide Versus Insulin Glargine on Cystatin C-Based Kidney Function: A SURPASS-4 Post Hoc Analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sattar N et al. (2026). Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide: A… [PMID: 42233927]
Laboratory literature summary: Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide: A SURMOUNT-1 Post Hoc Analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
van der Walle EEPL et al. (2026). Laboratory research record on GLP-2T [PMID: 41926561]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Minoda Y et al. (2026). Laboratory research record on GLP-2T [PMID: 41840480]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
McKone DB et al. (2025). Laboratory research record on GLP-2T [PMID: 40823594]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wu JY et al. (2025). Laboratory research record on GLP-2T [PMID: 40049522]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Kamrul-Hasan A et al. (2025). Laboratory research record on GLP-2T [PMID: 39959269]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wadden TA et al. (2023). Laboratory research record on GLP-2T [PMID: 37840095]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Choudhuri B (2026). Targeted Ileal Bile Acid Transporter Inhibition as Rescue research protocol for… [PMID: 42421979]
Laboratory literature summary: Targeted Ileal Bile Acid Transporter Inhibition as Rescue research protocol for Tirzepatide-Induced Severe Constipation: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Goraya R et al. (2026). Tirzepatide: A turning point in metabolic research models related heart failure with… [PMID: 42363364]
Laboratory literature summary: Tirzepatide: A turning point in metabolic research models related heart failure with preserved ejection fraction?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2025). Laboratory research record on GLP-2T [PMID: 40832789]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Guo X et al. (2023). Laboratory research record on GLP-2T [PMID: 37701028]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Scheen A (2025). Laboratory research record on GLP-2T [PMID: 40931739]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Papantoniou P et al. (2025). A Short-Term Cost-Effectiveness Analysis of Tirzepatide Versus Semaglutide for the… [PMID: 40868627]
Laboratory literature summary: A Short-Term Cost-Effectiveness Analysis of Tirzepatide Versus Semaglutide for the investigation of metabolic research models in Greece. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Delvadia P et al. (2025). Dual GLP-1 and GIP Agonist Tirzepatide Exerted Neuroprotective Action in a… [PMID: 39964252]
Laboratory literature summary: Dual GLP-1 and GIP Agonist Tirzepatide Exerted Neuroprotective Action in a neurodegeneration research models's Disease Rat Model. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jacob S et al. (2024). Laboratory research record on GLP-2T [PMID: 38247052]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Skelley JW et al. (2024). The impact of tirzepatide and glucagon-like peptide 1 receptor agonists on oral… [PMID: 37940101]
Laboratory literature summary: The impact of tirzepatide and glucagon-like peptide 1 receptor agonists on oral hormonal contraception. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Carducci A et al. (2026). Possible Attenuation of Early body-composition research During Tirzepatide research… [PMID: 42502530]
Laboratory literature summary: Possible Attenuation of Early body-composition research During Tirzepatide research protocol in a research subjects studied With…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Builes-Montaño CE et al. (2026). Laboratory research record on GLP-2T [PMID: 42252377]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Zhang Y et al. (2026). Tirzepatide attenuates lipopolysaccharide-induced acute lung injury via AMPK/NF-κB… [PMID: 42119472]
Laboratory literature summary: Tirzepatide attenuates lipopolysaccharide-induced acute lung injury via AMPK/NF-κB signaling pathway. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Olewi NZ et al. (2026). Possible protective effects of tirzepatide on polycystic ovary syndrome in research… [PMID: 42065757]
Laboratory literature summary: Possible protective effects of tirzepatide on polycystic ovary syndrome in research models rat model induced by androgen-pathway markers…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zou X et al. (2025). Understanding the activation mechanism of GLP-1R/GIPR by dual agonist Tirzepatide via… [PMID: 40692063]
Laboratory literature summary: Understanding the activation mechanism of GLP-1R/GIPR by dual agonist Tirzepatide via molecular dynamics and protein-peptide binding. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
d'Aquino AI et al. (2025). Laboratory research record on GLP-2T [PMID: 40631235]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Bradley CL et al. (2023). Laboratory research record on GLP-2T [PMID: 36367094]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Chandra KP et al. (2026). Laboratory research record on GLP-2T [PMID: 41798487]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Tang M et al. (2025). Laboratory research record on GLP-2T [PMID: 40452343]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Rochira V et al. (2024). Laboratory research record on GLP-2T [PMID: 39329873]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Lingvay I et al. (2023). Laboratory research record on GLP-2T [PMID: 36964557]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Corso H et al. (2026). Laboratory research record on GLP-2T [PMID: 42488012]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Yasui-Furukori N et al. (2026). Starvation ketosis following self-administered tirzepatide obtained via online… [PMID: 42243968]
Laboratory literature summary: Starvation ketosis following self-administered tirzepatide obtained via online services in a young woman later analytical assessment…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ng CD et al. (2025). Laboratory research record on GLP-2T [PMID: 40875186]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Rees TA et al. (2024). Tirzepatide, GIP(1-42) and GIP(1-30) display unique signaling profiles at two common… [PMID: 39464637]
Laboratory literature summary: Tirzepatide, GIP(1-42) and GIP(1-30) display unique signaling profiles at two common GIP receptor variants, E354 and Q354. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Frías JP et al. (2024). Laboratory research record on GLP-2T [PMID: 37602701]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Kushner P et al. (2023). Laboratory research record on GLP-2T [PMID: 37092144]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
McCormick NP et al. (2026). Use of Semaglutide and Tirzepatide in Rheumatic and Musculoskeletal Diseases: Insights… [PMID: 42101387]
Laboratory literature summary: Use of Semaglutide and Tirzepatide in Rheumatic and Musculoskeletal Diseases: Insights on Initiation Patterns and body-composition…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Khan I (2025). Care of dental research subjects on glucagon-like peptide-1 receptor agonists or… [PMID: 40148608]
Laboratory literature summary: Care of dental research subjects on glucagon-like peptide-1 receptor agonists or tirzepatide requiring sedation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bi Y et al. (2024). Laboratory research record on GLP-2T [PMID: 38494574]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Rosenstock J et al. (2024). Impact on glycated haemoglobin and body weight changes after stopping tirzepatide for… [PMID: 37880822]
Laboratory literature summary: Impact on glycated haemoglobin and body weight changes after stopping tirzepatide for 4 weeks in the SURPASS-1 monotherapy trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kahkedjian F et al. (2026). Tirzepatide and reduced risk of pulmonary embolism and deep vein thrombosis: a… [PMID: 42460324]
Laboratory literature summary: Tirzepatide and reduced risk of pulmonary embolism and deep vein thrombosis: a multicenter U.S. cohort study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Noreña JA et al. (2026). Beyond body-composition research: tirzepatide as a dual GIP/GLP-1 receptor agonist for… [PMID: 41405280]
Laboratory literature summary: Beyond body-composition research: tirzepatide as a dual GIP/GLP-1 receptor agonist for obstructive sleep apnea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Toga-Sato S et al. (2025). Laboratory research record on GLP-2T [PMID: 41111575]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wang R et al. (2025). The role of gut microbiota in Tirzepatide-mediated alleviation of high-fat… [PMID: 40516844]
Laboratory literature summary: The role of gut microbiota in Tirzepatide-mediated alleviation of high-fat diet-induced metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bradley CL et al. (2024). Laboratory research record on GLP-2T [PMID: 38247049]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Lee CJ et al. (2023). Laboratory research record on GLP-2T [PMID: 37153701]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Pirro V et al. (2022). Laboratory research record on GLP-2T [PMID: 34608929]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Maqsood A et al. (2026). non-approved investigational GLP-1 receptor agonist and tirzepatide use for body-composition research:… [PMID: 42433852]
Laboratory literature summary: non-approved investigational GLP-1 receptor agonist and tirzepatide use for body-composition research: research subjects laboratory profile and regulatory…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Baba AH et al. (2026). Comparative observed endpoints and laboratory profile of Tirzepatide versus… [PMID: 42211533]
Laboratory literature summary: Comparative observed endpoints and laboratory profile of Tirzepatide versus Semaglutide: A Systematic Review and Meta-Analysis with…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fang Q et al. (2026). GLP-1/GIP dual agonist tirzepatide in obstructive sleep apnea syndrome: mechanisms,… [PMID: 42136855]
Laboratory literature summary: GLP-1/GIP dual agonist tirzepatide in obstructive sleep apnea syndrome: mechanisms, evidence, and laboratory perspectives. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Benny O et al. (2026). Exposure level-response analysis of tirzepatide and acute pancreatitis: An… [PMID: 41927408]
Laboratory literature summary: exposure level-response analysis of tirzepatide and acute pancreatitis: An international systematic review and quantitative…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zufry H et al. (2026). Head-to-head comparison of tirzepatide and semaglutide for body-composition research:… [PMID: 41723034]
Laboratory literature summary: Head-to-head comparison of tirzepatide and semaglutide for body-composition research: A systematic review and meta-analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Garg SK et al. (2025). Laboratory research record on GLP-2T [PMID: 40098470]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Rangraze IR et al. (2024). Role of Dual GIP and GLP-1 Receptor Agonist, Tirzepatide in the Management of… [PMID: 39484756]
Laboratory literature summary: Role of Dual GIP and GLP-1 Receptor Agonist, Tirzepatide in the Management of body-composition research; A Systematic Review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tobaiqy M et al. (2024). Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a… [PMID: 38265519]
Laboratory literature summary: Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Patoulias D et al. (2023). Laboratory research record on GLP-2T [PMID: 37552101]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Amioka M et al. (2026). Laboratory research record on GLP-2T [PMID: 42521631]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Schiavo L et al. (2026). Short-Term Associations Between Fat-Free Mass Preservation and Glycaemic Markers… [PMID: 41978142]
Laboratory literature summary: Short-Term Associations Between Fat-Free Mass Preservation and Glycaemic Markers During Tirzepatide research protocol: A Secondary…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cetiner S (2026). Laboratory research record on GLP-2T [PMID: 41938643]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Schmidt PHS et al. (2026). Laboratory research record on GLP-2T [PMID: 41705736]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Almandoz JP et al. (2026). Laboratory research record on GLP-2T [PMID: 41640675]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Zhang Y et al. (2025). The Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide Attenuates Colon oncology… [PMID: 40125821]
Laboratory literature summary: The Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide Attenuates Colon oncology research models Development by Regulating Glucose…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kamrul-Hasan ABM et al. (2024). Pancreatic laboratory profile of Tirzepatide and Its Effects on Islet Cell Function: A… [PMID: 39720158]
Laboratory literature summary: Pancreatic laboratory profile of Tirzepatide and Its Effects on Islet Cell Function: A Systematic Review and Meta-Analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tian Y et al. (2025). Laboratory research record on GLP-2T [PMID: 39700965]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Forny Germano L et al. (2024). The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related… [PMID: 39216535]
Laboratory literature summary: The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tan B et al. (2023). Laboratory research record on GLP-2T [PMID: 37253796]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Bajaj HS et al. (2026). Tirzepatide as an Add-on for Participants with Inadequate Glycemic Control Using Basal… [PMID: 41961454]
Laboratory literature summary: Tirzepatide as an Add-on for Participants with Inadequate Glycemic Control Using Basal Insulin: Pooled Subgroup Analysis of SURPASS-5 and -6. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Corrao S (2026). Laboratory research record on GLP-2T [PMID: 41914139]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Aronne LJ et al. (2026). Relationship of early rapid body-composition research to observed endpoints and… [PMID: 41865857]
Laboratory literature summary: Relationship of early rapid body-composition research to observed endpoints and laboratory profile of tirzepatide and semaglutide for…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Talay L et al. (2026). Effectiveness and adherence in a tirzepatide-supported digital body-composition… [PMID: 41532325]
Laboratory literature summary: Effectiveness and adherence in a tirzepatide-supported digital body-composition research programme in Australia: A real-world…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wu JY et al. (2025). Tirzepatide and the Prevention of Heart Failure in metabolic research models: A… [PMID: 41123417]
Laboratory literature summary: Tirzepatide and the Prevention of Heart Failure in metabolic research models: A Multi-Center Cohort Study Using the TriNetX Database. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Linetzky B et al. (2025). Laboratory research record on GLP-2T [PMID: 40550133]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wu JY et al. (2025). Laboratory research record on GLP-2T [PMID: 40412626]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wadden TA et al. (2024). Laboratory research record on GLP-2T [PMID: 38409593]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Gibble TH et al. (2026). Laboratory research record on GLP-2T [PMID: 42491427]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Jacobsen L et al. (2026). Peritoneal Incretin Deficiency and Tirzepatide as a Multi-Axis Adjuvant Hypothesis in… [PMID: 42449952]
Laboratory literature summary: Peritoneal Incretin Deficiency and Tirzepatide as a Multi-Axis Adjuvant Hypothesis in investigation-Refractory Endometriosis: A…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Alawadhi AA et al. (2026). LEAN mass Preservation with Resistance Exercise and Protein during semaglutide and… [PMID: 42020128]
Laboratory literature summary: LEAN mass Preservation with Resistance Exercise and Protein during semaglutide and tirzepatide research protocol (LEAN-PREP study): a…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Huang L et al. (2026). Laboratory research record on GLP-2T [PMID: 41962807]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Violante-Ortiz R et al. (2026). Laboratory profile and observed endpoints of switching from dulaglutide to tirzepatide… [PMID: 41912265]
Laboratory literature summary: laboratory profile and observed endpoints of switching from dulaglutide to tirzepatide across clinically relevant baseline…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Al Ozairi E et al. (2026). Laboratory research record on GLP-2T [PMID: 41048008]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
La Vignera S et al. (2025). Short-term impact of tirzepatide on metabolic hypogonadism and body composition in… [PMID: 40604795]
Laboratory literature summary: Short-term impact of tirzepatide on metabolic hypogonadism and body composition in research subjects with metabolic research models: a…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Akturk HK et al. (2025). Laboratory research record on GLP-2T [PMID: 38317405]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Boye KS et al. (2023). Laboratory research record on GLP-2T [PMID: 37526908]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Leslie DB et al. (2026). Laboratory research record on GLP-2T [PMID: 42309121]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Adamidis N et al. (2026). Effects of Tirzepatide on Body Composition, Metabolic Parameters, and Sleep Outcomes:… [PMID: 42147626]
Laboratory literature summary: Effects of Tirzepatide on Body Composition, Metabolic Parameters, and Sleep Outcomes: A Real-World One-Year Prospective Study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Corrêa LMA et al. (2026). Tirzepatide in solid organ transplant recipients: Early real-world signals of observed… [PMID: 41707409]
Laboratory literature summary: Tirzepatide in solid organ transplant recipients: Early real-world signals of observed endpoints and laboratory profile-A narrative review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kanu C et al. (2025). Effect of tirzepatide investigation on research subjects-reported outcomes among… [PMID: 40774158]
Laboratory literature summary: Effect of tirzepatide investigation on research subjects-reported outcomes among SURMOUNT-OSA participants with obstructive sleep apnea…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Alsararatee HH (2025). Novel finding of pulmonary embolism following tirzepatide (Manjaro) use in a young… [PMID: 40669882]
Laboratory literature summary: Novel finding of pulmonary embolism following tirzepatide (Manjaro) use in a young adult without risk factors of venous thromboembolic…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rohani P et al. (2023). Laboratory research record on GLP-2T [PMID: 37621649]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Mews K et al. (2025). Management of Hypoglycemia Using Continuous Glucose Monitoring During Tirzepatide… [PMID: 41257224]
Laboratory literature summary: Management of Hypoglycemia Using Continuous Glucose Monitoring During Tirzepatide Initiation or Uptitration When Used in Addition to…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cerchi E et al. (2025). Laboratory research record on GLP-2T [PMID: 41015578]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Schiavo L et al. (2025). Beyond body-composition research: Comparative Effects of Tirzepatide Plus Low-Energy… [PMID: 40805994]
Laboratory literature summary: Beyond body-composition research: Comparative Effects of Tirzepatide Plus Low-Energy Ketogenic Versus Low-Calorie Diet on Hepatic…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ard J et al. (2025). Laboratory research record on GLP-2T [PMID: 40677091]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Patel H et al. (2024). Laboratory research record on GLP-2T [PMID: 37853960]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Cho YK et al. (2023). The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and… [PMID: 37800107]
Laboratory literature summary: The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kido K et al. (2024). Call to action for drug interactions between tirzepatide and heart failure… [PMID: 37797920]
Laboratory literature summary: Call to action for drug interactions between tirzepatide and heart failure guideline-directed medical research protocol. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tall Bull S et al. (2022). Tirzepatide: A novel, first-in-class, dual GIP/GLP-1 receptor agonist [PMID: 36375235]
Laboratory literature summary: Tirzepatide: A novel, first-in-class, dual GIP/GLP-1 receptor agonist. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hong AT et al. (2026). Laboratory research record on GLP-2T [PMID: 41655764]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Liu L et al. (2025). Laboratory research record on GLP-2T [PMID: 41390457]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Sultan W et al. (2025). Laboratory research record on GLP-2T [PMID: 40746803]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Zhang A et al. (2025). Tirzepatide reduces body weight by increasing fat utilization via the central nervous… [PMID: 40000395]
Laboratory literature summary: Tirzepatide reduces body weight by increasing fat utilization via the central nervous system-adipose tissue axis in research models mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gong J et al. (2025). Laboratory research record on GLP-2T [PMID: 39569606]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Metcalfe RK et al. (2026). Laboratory research record on GLP-2T [PMID: 42383939]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Kiyosue A et al. (2026). Laboratory research record on GLP-2T [PMID: 42334799]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Mahar MU et al. (2024). Laboratory research record on GLP-2T [PMID: 39681390]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Osorio Manyari AA et al. (2025). Effects of Semaglutide and Tirzepatide on Recurrent Weight Gain After Bariatric… [PMID: 41313431]
Laboratory literature summary: Effects of Semaglutide and Tirzepatide on Recurrent Weight Gain After Bariatric Surgery: A Systematic Review and Meta-analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dani SS et al. (2025). An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like… [PMID: 40447342]
Laboratory literature summary: An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor Agonists. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chavda VP et al. (2025). Laboratory research record on GLP-2T [PMID: 40142172]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
El Khatib O et al. (2025). Laboratory profile and observed endpoints of Tirzepatide in Solid-Organ Transplant… [PMID: 39918190]
Laboratory literature summary: laboratory profile and observed endpoints of Tirzepatide in Solid-Organ Transplant Recipients: Experience of a Quaternary Care Center in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Naseralallah L et al. (2023). Laboratory research record on GLP-2T [PMID: 36820516]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Bucheit J et al. (2022). Laboratory research record on GLP-2T [PMID: 35767712]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Hsu Y et al. (2026). Laboratory research record on GLP-2T [PMID: 42378200]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Maradia J et al. (2026). Evaluating the antidepressant effects of tirzepatide on unpredictable chronic mild… [PMID: 42131414]
Laboratory literature summary: Evaluating the antidepressant effects of tirzepatide on unpredictable chronic mild stress-induced depression in Swiss Albino mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hankosky ER et al. (2025). Laboratory research record on GLP-2T [PMID: 39996368]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Rivera Gutierrez R et al. (2025). Laboratory research record on GLP-2T [PMID: 39601745]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Toki S et al. (2023). Laboratory research record on GLP-2T [PMID: 36377605]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Venerito V et al. (2026). Laboratory research record on GLP-2T [PMID: 42532547]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Mohamed ZI et al. (2026). Tirzepatide and SGLT2 Inhibitors for Heart Failure With Preserved Ejection Fraction… [PMID: 42533465]
Laboratory literature summary: Tirzepatide and SGLT2 Inhibitors for Heart Failure With Preserved Ejection Fraction and metabolic research models: Entering a New…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Abegaz TM et al. (2026). Cost-Effectiveness of Tirzepatide for the Management of Heart Failure With Preserved… [PMID: 42012431]
Laboratory literature summary: Cost-Effectiveness of Tirzepatide for the Management of Heart Failure With Preserved Ejection Fraction and metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Song Z et al. (2025). Laboratory research record on GLP-2T [PMID: 41011133]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Kelly MS et al. (2024). Laboratory research record on GLP-2T [PMID: 39248221]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Caruso I et al. (2024). Laboratory research record on GLP-2T [PMID: 38472620]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Azuri J et al. (2023). Laboratory research record on GLP-2T [PMID: 36507900]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Blanco Anesto J et al. (2026). [Tirzepatide in real-world laboratory practice: changes in body composition and muscle… [PMID: 42037504]
Laboratory literature summary: [Tirzepatide in real-world laboratory practice: changes in body composition and muscle function in research subjects with metabolic…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
le Roux CW et al. (2026). Comparative effectiveness of tirzepatide and semaglutide for metabolic research models… [PMID: 41661445]
Laboratory literature summary: Comparative effectiveness of tirzepatide and semaglutide for metabolic research models management in US laboratory practice: a 6-month…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nahar S et al. (2025). Severe Small-Bowel Obstruction in a High-Risk research subjects on Long-Term… [PMID: 41523550]
Laboratory literature summary: Severe Small-Bowel Obstruction in a High-Risk research subjects on Long-Term Tirzepatide research protocol: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tian R et al. (2025). GLP-1/GIP dual agonist tirzepatide alleviates mice model of neurodegeneration research… [PMID: 40886502]
Laboratory literature summary: GLP-1/GIP dual agonist tirzepatide alleviates mice model of neurodegeneration research models's disease by promoting mitochondrial…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kokkinos A et al. (2026). Tirzepatide observed endpoints and Tolerability According to Early Weight Response: A… [PMID: 42348366]
Laboratory literature summary: Tirzepatide observed endpoints and Tolerability According to Early Weight Response: A Post Hoc Analysis of the SURMOUNT-1 and SURMOUNT-2…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hepşen S et al. (2026). Real-World Comparison of Short-Term Adverse Events, investigation Persistence, and… [PMID: 42030208]
Laboratory literature summary: Real-World Comparison of Short-Term Adverse Events, investigation Persistence, and observed endpoints of Semaglutide and Tirzepatide: A…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lempesis IG et al. (2022). Laboratory research record on GLP-2T [PMID: 36530219]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Furihata K et al. (2022). Laboratory research record on GLP-2T [PMID: 34647404]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Shah T et al. (2026). Potential role of tirzepatide, a dual GLP-1 and GIP receptor agonist, for preventive… [PMID: 42403198]
Laboratory literature summary: Potential role of tirzepatide, a dual GLP-1 and GIP receptor agonist, for preventive investigation of migraine: A case series. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Knackstedt LA (2026). Novel evidence for tirzepatide, a dual GLP-1/GIP receptor agonist, to reduce the… [PMID: 41980479]
Laboratory literature summary: Novel evidence for tirzepatide, a dual GLP-1/GIP receptor agonist, to reduce the motivation for cocaine in rodents. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Horn DB et al. (2026). Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults… [PMID: 41284285]
Laboratory literature summary: Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With metabolic research models: A Post Hoc…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rhea EM et al. (2024). Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in… [PMID: 38095516]
Laboratory literature summary: Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new experimental regimens of neurodegeneration…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yang XY et al. (2023). Laboratory research record on GLP-2T [PMID: 37606127]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
le Roux CW et al. (2023). Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the investigation of… [PMID: 37344384]
Laboratory literature summary: Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the investigation of metabolic research models: An indirect investigation…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Belančić A et al. (2026). Comparative observed endpoints of GLP-1 RA, tirzepatide and SGLT-2 inhibitors in… [PMID: 41703425]
Laboratory literature summary: Comparative observed endpoints of GLP-1 RA, tirzepatide and SGLT-2 inhibitors in metabolic liver disease: A network meta-analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chen N et al. (2025). Laboratory research record on GLP-2T [PMID: 41089557]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Hankosky ER et al. (2025). Laboratory research record on GLP-2T [PMID: 40057019]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Kaore S et al. (2024). Laboratory research record on GLP-2T [PMID: 38665722]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Kaneko S (2022). Laboratory research record on GLP-2T [PMID: 35949358]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Adamidis N et al. (2026). Targeting Cellulite as a Metabolic-Dermal Interface: Effects of Tirzepatide and a… [PMID: 42147579]
Laboratory literature summary: Targeting Cellulite as a Metabolic-Dermal Interface: Effects of Tirzepatide and a Multi-Pathway Topical research protocol (G21) in a…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Johnson H et al. (2026). Digital Engagement Significantly Enhances body-composition research Outcomes in Adults… [PMID: 41538282]
Laboratory literature summary: Digital Engagement Significantly Enhances body-composition research Outcomes in Adults With metabolic research models studied With…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yokote K et al. (2026). Association of baseline characteristics with laboratory outcomes of tirzepatide… [PMID: 41290555]
Laboratory literature summary: Association of baseline characteristics with laboratory outcomes of tirzepatide investigation in Japanese research subjects with…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Snaith JR et al. (2026). Laboratory research record on GLP-2T [PMID: 41264593]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Sue M et al. (2025). Laboratory research record on GLP-2T [PMID: 39902194]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Karakus KE et al. (2024). Laboratory research record on GLP-2T [PMID: 38743306]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Boye KS et al. (2023). Laboratory research record on GLP-2T [PMID: 37668888]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Abe T et al. (2026). Laboratory research record on GLP-2T [PMID: 42289805]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Rahman MH et al. (2026). Laboratory research record on GLP-2T [PMID: 41342185]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Schmickl CN et al. (2026). Investigation preferences for comorbid metabolic research models and obstructive sleep… [PMID: 41731227]
Laboratory literature summary: investigation preferences for comorbid metabolic research models and obstructive sleep apnea (PRO-CON OSA) survey: research subjects and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sattar N et al. (2026). Laboratory research record on GLP-2T [PMID: 41198460]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Chigutsa E et al. (2025). A Pharmacometric Method for Quantitative Determination of Improvement in Body… [PMID: 40556483]
Laboratory literature summary: A Pharmacometric Method for Quantitative Determination of Improvement in Body Composition and Characterization of the Exposure-Response…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Misra S et al. (2025). Laboratory research record on GLP-2T [PMID: 39873719]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Liang J et al. (2025). Exploring the molecular mechanisms of tirzepatide in alleviating metabolic… [PMID: 39794823]
Laboratory literature summary: Exploring the molecular mechanisms of tirzepatide in alleviating metabolic dysfunction-associated fatty liver in mice through…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Malhotra A et al. (2024). Tirzepatide for the investigation of obstructive sleep apnea: Rationale, design, and… [PMID: 38547961]
Laboratory literature summary: Tirzepatide for the investigation of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Reitzel SB et al. (2023). Laboratory research record on GLP-2T [PMID: 37415503]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Galasso M et al. (2026). Tirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in… [PMID: 42518535]
Laboratory literature summary: Tirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in metabolic research models: a real-world multicenter…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Berry SA et al. (2026). Laboratory research record on GLP-2T [PMID: 42410316]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Zhou XY et al. (2026). Laboratory research record on GLP-2T [PMID: 42316327]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Hamarsheh S et al. (2026). Laboratory research record on GLP-2T [PMID: 42207966]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Khalil HA et al. (2026). A multimodal HPLC stability indicating approach for the estimation of Semaglutide and… [PMID: 41588418]
Laboratory literature summary: A multimodal HPLC stability indicating approach for the estimation of Semaglutide and Tirzepatide in bulk, pharmaceutical exposure…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Funamizu N et al. (2025). Laboratory research record on GLP-2T [PMID: 41137356]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Sharma D et al. (2025). Systemic Inflammatory Response Syndrome Following High-exposure level Intravenous… [PMID: 40556995]
Laboratory literature summary: Systemic Inflammatory Response Syndrome Following High-exposure level Intravenous Glutathione-Containing Revitalising Solution in a…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Thomas MK et al. (2021). Laboratory research record on GLP-2T [PMID: 33236115]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Chen HY et al. (2026). Laboratory research record on GLP-2T [PMID: 42435064]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Chaparala P et al. (2026). Laboratory research record on GLP-2T [PMID: 42326175]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Schmickl CN et al. (2025). Investigation Preferences For Comorbid metabolic research models and Obstructive Sleep… [PMID: 41256163]
Laboratory literature summary: investigation Preferences For Comorbid metabolic research models and Obstructive Sleep Apnea (PRO-CON OSA) Survey: research subjects and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wang LX et al. (2025). [Progress on tirzepatide, a GIP/GLP-1 receptor agonist, for the investigation of… [PMID: 41218868]
Laboratory literature summary: [Progress on tirzepatide, a GIP/GLP-1 receptor agonist, for the investigation of metabolic research models-related obstructive sleep apnea]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kishimori T et al. (2026). Laboratory research record on GLP-2T [PMID: 40945773]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wang D et al. (2025). Laboratory research record on GLP-2T [PMID: 40702450]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Author et al. (2025). Laboratory research record on GLP-2T [PMID: 39552537]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Nicholls SJ et al. (2024). Reduction of prevalence of research subjects meeting the criteria for metabolic… [PMID: 38341541]
Laboratory literature summary: Reduction of prevalence of research subjects meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wu JY et al. (2026). Tirzepatide and risk of newly analytical assessment aortic stenosis in research… [PMID: 42426654]
Laboratory literature summary: Tirzepatide and risk of newly analytical assessment aortic stenosis in research subjects with metabolic research models: a…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wang R et al. (2026). Long-Term Mechanical Complications After Lumbar Fusion in research subjects Receiving… [PMID: 42348793]
Laboratory literature summary: Long-Term Mechanical Complications After Lumbar Fusion in research subjects Receiving Tirzepatide vs Other GLP-1 Receptor Agonists. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Takahashi N et al. (2026). Laboratory research record on GLP-2T [PMID: 42217105]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Del Prato S et al. (2026). Laboratory research record on GLP-2T [PMID: 42184419]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Han C et al. (2026). Tirzepatide ameliorates cisplatin-induced acute kidney injury by restoring NAMPT/NAD +… [PMID: 42114682]
Laboratory literature summary: Tirzepatide ameliorates cisplatin-induced acute kidney injury by restoring NAMPT/NAD + homeostasis and enhancing Pink1-Parkin-mediated…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Agboola F et al. (2026). Semaglutide and tirzepatide for metabolic research models: A summary from the… [PMID: 42043926]
Laboratory literature summary: Semaglutide and tirzepatide for metabolic research models: A summary from the Institute for laboratory and Economic Review's New England…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chen D et al. (2026). Cardiovascular adverse event reporting profile of tirzepatide: a real-world… [PMID: 41948731]
Laboratory literature summary: Cardiovascular adverse event reporting profile of tirzepatide: a real-world pharmacovigilance analysis of heart failure, arrhythmias,…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mortada I et al. (2026). Laboratory research record on GLP-2T [PMID: 41862113]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Neves JS et al. (2026). Laboratory research record on GLP-2T [PMID: 41419618]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Ynalvez LA et al. (2025). In adults with HF with preserved ejection fraction and metabolic research models,… [PMID: 40163881]
Laboratory literature summary: In adults with HF with preserved ejection fraction and metabolic research models, tirzepatide reduced a composite of CV death or…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hellenkamp K et al. (2025). Reaching the SUMMIT? Benefits and potential risks associated with the use of… [PMID: 39954669]
Laboratory literature summary: Reaching the SUMMIT? Benefits and potential risks associated with the use of tirzepatide in heart failure with preserved ejection fraction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Liu L (2024). A real-world data analysis of tirzepatide in the FDA adverse event reporting system… [PMID: 38910884]
Laboratory literature summary: A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Qadeer A et al. (2026). Laboratory research record on GLP-2T [PMID: 42376874]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Schmickl CN et al. (2026). Correction: investigation preferences for comorbid metabolic research models and… [PMID: 42151574]
Laboratory literature summary: Correction: investigation preferences for comorbid metabolic research models and obstructive sleep apnea (PRO-CON OSA) survey: research…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rangraze IR et al. (2026). Persistence-Dependent Effectiveness of Tirzepatide on the Cardio-Metabolic-Kidney… [PMID: 42029986]
Laboratory literature summary: Persistence-Dependent Effectiveness of Tirzepatide on the Cardio-Metabolic-Kidney Syndrome Outcomes in metabolic research models:…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Merola JF et al. (2026). Laboratory research record on GLP-2T [PMID: 41903163]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Shukla AP et al. (2026). Laboratory research record on GLP-2T [PMID: 41187971]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
He YM et al. (2025). Laboratory research record on GLP-2T [PMID: 41100405]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Ostrominski JW et al. (2025). Trends in Utilization of Glucose- and Weight-Lowering Medications After Tirzepatide… [PMID: 40228298]
Laboratory literature summary: Trends in Utilization of Glucose- and Weight-Lowering Medications After Tirzepatide Approval in the United States: A Population-Based…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bergman BK et al. (2025). Laboratory research record on GLP-2T [PMID: 40083081]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Tang Y et al. (2022). Laboratory research record on GLP-2T [PMID: 36569320]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Min T et al. (2021). Laboratory research record on GLP-2T [PMID: 33325008]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Goldenberg RM et al. (2026). Laboratory research record on GLP-2T [PMID: 42115707]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Angelopoulos N et al. (2026). Six-Month Real-World Effectiveness, Persistence and laboratory profile of… [PMID: 42037110]
Laboratory literature summary: Six-Month Real-World Effectiveness, Persistence and laboratory profile of Low-to-Moderate exposure level Tirzepatide in Adults With…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Soliman A et al. (2026). Laboratory research record on GLP-2T [PMID: 41883513]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Castellana E et al. (2026). Exploring the Potential Link Between Tirzepatide and Non-Arteritic Anterior Ischemic… [PMID: 41509894]
Laboratory literature summary: Exploring the Potential Link Between Tirzepatide and Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION): Evidence from FAERS and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hong AT et al. (2026). Laboratory research record on GLP-2T [PMID: 41360342]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Marcondes-de-Castro IA et al. (2026). Laboratory research record on GLP-2T [PMID: 40974707]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Sattar N et al. (2025). Laboratory research record on GLP-2T [PMID: 40838997]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Buckley AJ et al. (2025). Laboratory research record on GLP-2T [PMID: 40637847]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wu JY et al. (2025). Comparing laboratory outcomes of adults with metabolic research models receiving… [PMID: 40109063]
Laboratory literature summary: Comparing laboratory outcomes of adults with metabolic research models receiving tirzepatide versus bariatric metabolic surgery: A…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rasouli N et al. (2025). Laboratory research record on GLP-2T [PMID: 40016573]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Chen C et al. (2025). Laboratory research record on GLP-2T [PMID: 42058132]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Munawar N et al. (2025). Laboratory research record on GLP-2T [PMID: 40666599]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Author et al. (2025). Laboratory research record on GLP-2T [PMID: 40340500]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Hamamoto Y et al. (2025). Laboratory research record on GLP-2T [PMID: 39951042]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Jensen TL et al. (2024). Laboratory research record on GLP-2T [PMID: 38352159]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Frías JP (2023). Laboratory research record on GLP-2T [PMID: 36908082]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Makhmutov A et al. (2026). Laboratory research record on GLP-2T [PMID: 42299163]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Minakata Y et al. (2026). Laboratory research record on GLP-2T [PMID: 41674229]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wu P et al. (2025). Tirzepatide alleviates non-alcoholic fatty liver disease by regulating lipid… [PMID: 41552345]
Laboratory literature summary: Tirzepatide alleviates non-alcoholic fatty liver disease by regulating lipid metabolism through activation of the AMPK/NF-κB signaling…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Iwasaki Y et al. (2026). Laboratory research record on GLP-2T [PMID: 41448390]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Hsu YH et al. (2025). Association of tirzepatide use with risk of osteoporosis compared with other GLP-1… [PMID: 41218687]
Laboratory literature summary: Association of tirzepatide use with risk of osteoporosis compared with other GLP-1 receptor agonists: A retrospective cohort study using…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mimura H et al. (2025). Laboratory research record on GLP-2T [PMID: 40711720]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Lim C et al. (2025). GLP-1 Receptor Agonists for Clozapine-Induced Weight Gain: A Case Report With the Dual… [PMID: 40650875]
Laboratory literature summary: GLP-1 Receptor Agonists for Clozapine-Induced Weight Gain: A Case Report With the Dual GLP-1/GIP Agonist Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ou Y et al. (2024). Analysis of tirzepatide in the US FDA adverse event reporting system (FAERS): a focus… [PMID: 39568578]
Laboratory literature summary: Analysis of tirzepatide in the US FDA adverse event reporting system (FAERS): a focus on overall research subjects population and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Davidson MB (2023). Laboratory research record on GLP-2T [PMID: 37931265]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wu JY et al. (2026). Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on… [PMID: 42009260]
Laboratory literature summary: Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on cardiovascular-kidney-metabolic stage progression: a…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Maruyama F et al. (2026). Laboratory research record on GLP-2T [PMID: 41944182]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Takizawa H et al. (2026). Laboratory research record on GLP-2T [PMID: 41925328]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Zile MR et al. (2025). Response by Zile et al to Letter Regarding Article, "Effects of Tirzepatide on the… [PMID: 41212937]
Laboratory literature summary: Response by Zile et al to Letter Regarding Article, "Effects of Tirzepatide on the laboratory Trajectory of research subjects With Heart…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tong K et al. (2023). Laboratory research record on GLP-2T [PMID: 37904345]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Yabe D et al. (2023). Laboratory research record on GLP-2T [PMID: 36184780]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Vadher K et al. (2022). Laboratory research record on GLP-2T [PMID: 35589616]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Kitamoto T et al. (2026). Tirzepatide compared with semaglutide in metabolic research models disease: a… [PMID: 42434924]
Laboratory literature summary: Tirzepatide compared with semaglutide in metabolic research models disease: a subpopulation analysis applying Japan Society for the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Purcell AR et al. (2026). Laboratory research record on GLP-2T [PMID: 42387290]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Sacks GI et al. (2026). Laboratory research record on GLP-2T [PMID: 42315695]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Zhao N et al. (2025). Letter by Zhao et al Regarding Article, "Effects of Tirzepatide on the laboratory… [PMID: 41212939]
Laboratory literature summary: Letter by Zhao et al Regarding Article, "Effects of Tirzepatide on the laboratory Trajectory of research subjects With Heart Failure,…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pardeshi G et al. (2026). Laboratory research record on GLP-2T [PMID: 40832978]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Gojani EG et al. (2025). Single and Combined Impact of Semaglutide, Tirzepatide, and Metformin on β-Cell… [PMID: 39796271]
Laboratory literature summary: Single and Combined Impact of Semaglutide, Tirzepatide, and Metformin on β-Cell Maintenance and Function Under High-Glucose-High-Lipid…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ma J et al. (2024). Laboratory research record on GLP-2T [PMID: 38302718]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Morningstar M et al. (2023). Novel cannabinoid receptor 1 inverse agonist CRB-913 enhances observed endpoints of… [PMID: 37840407]
Laboratory literature summary: Novel cannabinoid receptor 1 inverse agonist CRB-913 enhances observed endpoints of tirzepatide, semaglutide, and liraglutidein the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhang X et al. (2023). Laboratory research record on GLP-2T [PMID: 36840958]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Hartman ML et al. (2020). Laboratory research record on GLP-2T [PMID: 32291277]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Silva JPMRJ et al. (2026). Laboratory research record on GLP-2T [PMID: 42410309]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Thirugnanam AM et al. (2026). Laboratory research record on GLP-2T [PMID: 42000295]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Gibble TH et al. (2025). Laboratory research record on GLP-2T [PMID: 40903801]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Hu W et al. (2025). Laboratory research record on GLP-2T [PMID: 39752752]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Mima A et al. (2024). Laboratory research record on GLP-2T [PMID: 38718272]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Zeitler P et al. (2024). Laboratory research record on GLP-2T [PMID: 38639997]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Mortada I et al. (2026). Laboratory research record on GLP-2T [PMID: 42516860]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Agrawal PK et al. (2026). Laboratory research record on GLP-2T [PMID: 42124821]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Zoungas S et al. (2026). Laboratory research record on GLP-2T [PMID: 42114520]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Acucella GA et al. (2026). Laboratory research record on GLP-2T [PMID: 42007544]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Akturk HK et al. (2026). Laboratory research record on GLP-2T [PMID: 41804540]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Tan L et al. (2026). Tirzepatide mitigates thoracic aortic aneurysm and dissection by alleviating the loss… [PMID: 41610999]
Laboratory literature summary: Tirzepatide mitigates thoracic aortic aneurysm and dissection by alleviating the loss of the contractile phenotype in vascular smooth…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wang JY et al. (2025). Exploring the observed endpoints and laboratory profile of Tirzepatide in metabolic… [PMID: 40685889]
Laboratory literature summary: Exploring the observed endpoints and laboratory profile of Tirzepatide in metabolic research models Management and Cardiometabolic Risk…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yamauchi T et al. (2025). Laboratory research record on GLP-2T [PMID: 40490415]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Wen J et al. (2025). Laboratory research record on GLP-2T [PMID: 40184508]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Mody R et al. (2025). Laboratory research record on GLP-2T [PMID: 40181696]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Talay L et al. (2025). 12-Month body-composition research and Adherence Predictors in a Real-World UK… [PMID: 41516991]
Laboratory literature summary: 12-Month body-composition research and Adherence Predictors in a Real-World UK Tirzepatide-Supported Digital metabolic research models…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yoneda M et al. (2026). Laboratory research record on GLP-2T [PMID: 41144905]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Godfrey H et al. (2025). Alopecia associated with the use of semaglutide and tirzepatide: A disproportionality… [PMID: 38925559]
Laboratory literature summary: Alopecia associated with the use of semaglutide and tirzepatide: A disproportionality analysis using the FDA adverse event reporting…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cai W et al. (2024). Laboratory research record on GLP-2T [PMID: 38356942]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Permana H et al. (2022). Laboratory research record on GLP-2T [PMID: 36274410]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Masuzaki H et al. (2026). Effect of Tirzepatide on Health-Related Quality of Life in Japanese research subjects… [PMID: 42108080]
Laboratory literature summary: Effect of Tirzepatide on Health-Related Quality of Life in Japanese research subjects With metabolic research models Disease: research…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ostrominski JW et al. (2026). Laboratory research record on GLP-2T [PMID: 41778928]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Hassan MG et al. (2025). Tirzepatide gains US Food and Drug Administration approval for the management of… [PMID: 40569229]
Laboratory literature summary: Tirzepatide gains US Food and Drug Administration approval for the management of obstructive sleep apnea: Implications for oral health…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Matsushiro M et al. (2025). Laboratory research record on GLP-2T [PMID: 39895173]
PubMed laboratory record discussing GLP-2T in a research context. Review the full methods and limitations on PubMed; research use only.
Caruso I et al. (2024). The real-world laboratory profile profile of tirzepatide: pharmacovigilance analysis… [PMID: 39141075]
Laboratory literature summary: The real-world laboratory profile profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS)…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

Browse the full PubMed index: PubMed search.

Additional information

Weight	.125 lbs
Dimensions	9 × 7 × .5 in
Size: No selection	2mg, 5mg, 10mg, 20mg, 30mg, 40mg, 50mg, 60mg

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.

Frequently Asked Questions

What is GLP-2 peptide?

GLP-2 (Glucagon-Like Peptide-2) is a naturally occurring peptide involved in gastrointestinal signaling. It is commonly studied in research laboratories for its role in intestinal and metabolic pathways.

What is GLP-2 used for in research?

GLP-2 is used in research laboratories to investigate gut-related biological processes, nutrient signaling, and intestinal pathway activity. It is not approved for human use.

Is GLP-2T Peptide approved or intended for human use?

No. GLP-2 is strictly intended for research purposes only and is not approved by the FDA for human use.

Is GLP-2T Peptide FDA-approved for medical or clinical use?

No. GLP-2 peptide products are not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.

In what form is GLP-2 supplied?

GLP-2 is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research laboratories.

How should GLP-2 be stored?

Store sealed, lyophilized peptides protected from light and humidity at -4°F or colder; refrigeration (~39°F) is suitable for short-term use.

What vial sizes are available for GLP-2?

GLP-2 is available in multiple vial sizes.

Is GLP-2T Peptide sold as a prescription product?

No prescription is required; however, it is sold strictly for research use only.

How is GLP-2 shipped?

Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit. For more info, visit: https://www.nationwidepeptides.com/shipping-and-payments/

How can I verify GLP-2 purity and quality?

Product quality is supported through third-party laboratory testing and Certificates of Analysis (COA), confirming purity and batch consistency. For more info, visit: https://www.nationwidepeptides.com/coa/

Frequently bought together

GLP-2T Peptide

Bacteriostatic Water (Bac Water) research-grade

Bacteriostatic Water (Bac Water) - 10ml

$16.00

	Product		Price
	Bacteriostatic Water (Bac Water) - 10ml
	GLP-2T Peptide

Frequently Asked Questions

What is GLP-2 peptide?

What is GLP-2 used for in research?

GLP-2 is used in research laboratories to investigate gut-related biological processes, nutrient signaling, and intestinal pathway activity. It is not approved for human use.

Is GLP-2T Peptide approved or intended for human use?

No. GLP-2 is strictly intended for research purposes only and is not approved by the FDA for human use.

Is GLP-2T Peptide FDA-approved for medical or clinical use?

No. GLP-2 peptide products are not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.

In what form is GLP-2 supplied?

GLP-2 is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research laboratories.

How should GLP-2 be stored?

Store sealed, lyophilized peptides protected from light and humidity at -4°F or colder; refrigeration (~39°F) is suitable for short-term use.

What vial sizes are available for GLP-2?

GLP-2 is available in multiple vial sizes.

Is GLP-2T Peptide sold as a prescription product?

No prescription is required; however, it is sold strictly for research use only.

How is GLP-2 shipped?

Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit. For more info, visit: https://www.nationwidepeptides.com/shipping-and-payments/

How can I verify GLP-2 purity and quality?

SKU: GLP-2T Category: All Peptides Tags: Gattex, glp-1t, GLP-2, GLP-2T, GLP2, GLP2T, Glucagon-like peptide 2, Revestive, Teduglutide, tirzepatide Brand: Nationwide Peptides

Follow Us

Want to chat?

GLP-2T Peptide

Overview

Research Context for GLP-2T Peptide

Documented Attributes